Infectious Disease and Microbiology – Trichosporon beigelii

Overview

Trichosporon beigelii is a yeast-like fungus capable of forming arthroconidia, hyphae, blastoconidia, and pseudohyphae. It is best known for causing white piedra, a superficial infection of the hair shaft, but it can also produce invasive systemic infection in severely immunocompromised patients.

The organism is found in the environment, especially soil, and occurs in both tropical and temperate regions.

Classification

Genus: Trichosporon

Species: Trichosporon beigelii

Organism: Yeast-like fungus

A useful modern point is that the older name T. beigelii has historically been applied broadly, while clinically important infections are now attributed to several Trichosporon species.

Microbiologic Characteristics

Trichosporon can produce:

• Arthroconidia

• Blastoconidia

• True hyphae

• Pseudohyphae

This combination gives the organism a somewhat mixed:

Yeast + filamentous fungal appearance

High-Yield Microbiology Pattern

Yeast-like fungus

• ●

Arthroconidia

• ●

Hyphae and pseudohyphae

• ●

White hair-shaft concretions

→ Think TRICHOSPORON

Incubation Period

The incubation period is:

Unknown

Superficial infection may persist chronically before becoming clinically apparent.

Epidemiology

Trichosporon species are environmental organisms found in:

• Soil

• Water

• Organic material

They occur worldwide.

The source notes greater frequency in:

Tropical regions

although infection also occurs in:

Temperate climates

White Piedra

The classic superficial infection is:

WHITE PIEDRA

This is an infection involving the:

Hair shaft

rather than deeper skin structures.

Clinical Appearance of White Piedra

White piedra produces small:

Soft, pale, yellowish-white concretions

attached to the hair shaft.

These nodules may involve hair of the:

• Scalp

• Beard

• Mustache

• Axilla

• Pubic region

High-Yield White Piedra Pattern

Soft pale/yellow-white nodules

• ●

Hair shaft

• ●

Yeast forming arthroconidia

→ Think Trichosporon

White Piedra vs. Black Piedra

This is a classic examination comparison.

White Piedra

Organism: Trichosporon species

Nodules: Soft, white, cream, or yellowish

Hair involvement: Hair shaft

Black Piedra

Organism: Piedraia hortae

Nodules: Hard, black, firmly adherent

Memory Aid

WHITE = TRICHOSPORON

BLACK = PIEDRAIA

And:

Soft + white

→ Trichosporon

Hard + black

→ Piedraia hortae

Invasive Trichosporonosis

Although superficial disease is relatively benign, Trichosporon can cause:

SYSTEMIC INFECTION

in patients with severe impairment of host defenses.

Major Risk Groups

Invasive infection is particularly associated with:

• Hematologic malignancy

• Neutropenia

• Organ transplantation

• Advanced HIV infection

• Prolonged hospitalization

• Central venous catheters

• Broad-spectrum antibiotic exposure

Clinical Manifestations of Invasive Disease

Disseminated infection may cause:

• Fungemia

• Persistent fever

• Pulmonary infection

• Skin lesions

• Renal involvement

• Hepatic involvement

• Multiorgan dissemination

The clinical picture can resemble:

Invasive candidiasis

Skin Lesions in Disseminated Disease

Systemic trichosporonosis may produce:

Papular or nodular skin lesions

which can provide an accessible site for:

Biopsy and fungal identification

Diagnosis

The source lists:

• Culture

• Histopathology

as important diagnostic methods.

Culture

Culture can demonstrate a yeast-like fungus capable of producing:

Arthroconidia

This morphology helps distinguish Trichosporon from many other yeasts.

Histopathology

Tissue specimens may demonstrate:

• Yeast forms

• Hyphae

• Pseudohyphae

• Arthroconidia

Histopathology is especially important when evaluating:

Invasive disease

because it helps demonstrate true tissue invasion rather than colonization.

Cryptococcal Antigen Cross-Reactivity

An important diagnostic pearl from the source is:

FALSE-POSITIVE CRYPTOCOCCAL ANTIGEN TEST

Systemic Trichosporon infection can occasionally cause a false-positive result with:

Latex agglutination cryptococcal antigen testing

This occurs because of antigenic cross-reactivity.

High-Yield Diagnostic Pearl

Immunocompromised patient

• ●

Fungemia/systemic fungal infection

• ●

Positive cryptococcal antigen

but

Culture grows arthroconidia-forming yeast

→ Consider Trichosporon

Treatment of White Piedra

The source recommends:

Shaving the affected hair

followed by:

Topical azole therapy

Why Hair Removal Helps

Because the fungus colonizes and forms concretions around the:

Hair shaft

physical removal of affected hair decreases the fungal burden and improves treatment success.

Systemic Treatment

In invasive trichosporonosis, treatment requires:

SYSTEMIC ANTIFUNGAL THERAPY

The source notes that treatment data are limited.

Historically, options have included:

• Amphotericin B

• Voriconazole

Important Treatment Pearl

For invasive Trichosporon infections, azoles—particularly:

Voriconazole

are often considered important therapeutic agents.

Susceptibility can vary, so therapy should ideally be guided by:

Species identification + antifungal susceptibility + clinical severity

Amphotericin B

Although the source lists amphotericin B as potentially helpful, activity can be:

Variable

and invasive trichosporonosis can be difficult to treat.

Therefore, successful management often depends on:

• Effective systemic antifungal therapy

• Recovery from neutropenia when possible

• Removal of infected vascular devices when relevant

• Control of the underlying immunosuppressive condition

Source Control

In invasive disease, management may include:

Removal of central venous catheters

if they are suspected to be the source of fungemia.

Trichosporon vs. Candida

Both can produce yeast-like infections and pseudohyphae.

Trichosporon

→ Arthroconidia

→ White piedra

→ Invasive disease in immunocompromised hosts

→ May cause false-positive cryptococcal antigen

Candida

→ Budding yeast + pseudohyphae

→ Thrush, vaginitis, candidemia

→ Does not classically produce white piedra

Trichosporon vs. Geotrichum

Both can form:

Arthroconidia

Trichosporon

→ Arthroconidia + blastoconidia

→ White piedra

→ Opportunistic systemic infection

Geotrichum

→ Prominent rectangular arthroconidia

→ Usually lacks prominent blastoconidia

→ Rare opportunistic geotrichosis

Trichosporon vs. Piedraia hortae

Trichosporon

→ White piedra

→ Soft, pale nodules

→ Yeast-like organism

Piedraia hortae

→ Black piedra

→ Hard, black nodules

→ Dematiaceous fungus

High-Yield Clinical Pattern

Soft white/yellow hair-shaft nodules

• ●

Yeast with arthroconidia and pseudohyphae

→ Think WHITE PIEDRA due to Trichosporon

High-Yield Invasive Pattern

Neutropenic/transplant/immunocompromised patient

• ●

Persistent fungemia

• ●

Arthroconidia-forming yeast

• ●

Possible false-positive cryptococcal antigen

→ Think INVASIVE TRICHOSPORONOSIS

Exam Essentials

Genus: Trichosporon

Historical species: T. beigelii

Organism: Yeast-like fungus

Morphology: Arthroconidia + blastoconidia + hyphae + pseudohyphae

Distribution: Worldwide

Environmental reservoir: Soil and other environmental sources

Classic superficial disease: White piedra

White piedra finding: Soft yellowish-white concretions on hair shafts

Major invasive risk groups: Neutropenia, transplantation, advanced HIV, severe immunosuppression

Systemic disease: Fungemia and disseminated infection

Diagnosis: Culture + histopathology

Diagnostic pearl: May cause false-positive cryptococcal antigen testing

White piedra treatment: Shaving/removal of affected hair + topical azole

Systemic treatment: Systemic antifungal therapy, with voriconazole an important option

Source control: Consider removal of infected vascular devices

Memory Aid

TRICHOSPORON = TRICHO = HAIR

Think:

TRICHO

→ Hair

→ White concretions

→ White piedra

And:

WHITE + SOFT = TRICHOSPORON

BLACK + HARD = PIEDRAIA

Key clinical pearl: Trichosporon is an arthroconidia-forming yeast-like fungus classically associated with white piedra, producing soft pale or yellowish concretions on hair shafts. In severely immunocompromised patients it can become an invasive pathogen causing fungemia and disseminated disease. Culture and histopathology are central to diagnosis, and systemic infection can occasionally produce a false-positive cryptococcal antigen test.

Infectious Disease and Microbiology – Trichinella spiralis

Overview

Trichinella spiralis is a nematode helminth (roundworm) that causes trichinellosis, also known as trichinosis. Humans acquire infection by eating raw or inadequately cooked meat containing encysted larvae, classically pork but also meat from wild animals such as bear, wild boar, and other carnivorous or omnivorous animals.

The severity of disease depends largely on the number of larvae ingested and host factors. Many infections are asymptomatic, while heavy infections can produce a characteristic combination of gastrointestinal symptoms, fever, marked eosinophilia, periorbital edema, and diffuse myalgia.

Classification

Genus: Trichinella

Species: Trichinella spiralis

Organism: Nematode helminth (roundworm)

Disease: Trichinellosis / trichinosis

Microbiologic Characteristics

T. spiralis is a:

• Tissue-invasive nematode

• Foodborne helminth

• Parasite whose larvae become encysted in striated skeletal muscle

• Infection associated with consumption of inadequately cooked infected meat

Unlike many intestinal nematodes, the most clinically important manifestations occur when:

Larvae migrate from the intestine into skeletal muscle and other tissues.

High-Yield Microbiology Pattern

Nematode

• ●

Undercooked pork or wild-game meat

• ●

Periorbital edema

• ●

Diffuse myalgia

• ●

Marked eosinophilia

→ Think TRICHINELLA SPIRALIS

Incubation Period

The clinical course can be divided into an early:

Intestinal phase

and a later:

Systemic/muscular phase

Gastrointestinal Phase

Gastrointestinal symptoms may begin:

Within a few days after infection

after ingestion of contaminated meat.

Systemic Phase

Systemic manifestations generally develop approximately:

5–45 days after infection

as larvae disseminate and invade tissues.

Epidemiology

T. spiralis has a:

Worldwide distribution

The incidence varies according to:

• Food preparation practices

• Consumption of raw or undercooked pork

• Consumption of wild-game meat

• Animal husbandry practices

• Meat inspection and food-safety practices

Important Food Exposures

Classically associated foods include:

• Pork

• Wild boar

• Bear meat

• Other inadequately cooked wild-animal meat

The source also identifies animals such as:

Foxes

as potential wildlife reservoirs.

High-Yield Exposure Pattern

Raw/undercooked pork

or

Wild-game meat

↓

Encysted Trichinella larvae

↓

Intestinal infection

↓

Larval dissemination

↓

Skeletal muscle invasion

Life Cycle

Humans become infected by eating meat containing:

ENCYSTED LARVAE

The larvae are released during digestion.

↓

They mature into adult worms in the:

Small intestine

↓

Adult females release larvae.

↓

Larvae penetrate the intestinal mucosa.

↓

They enter the:

Bloodstream and lymphatic circulation

↓

Larvae disseminate throughout the body.

↓

They preferentially invade:

Striated skeletal muscle

↓

The larvae become established within specialized muscle cells.

Clinical Infection

The disease is called:

TRICHINELLOSIS

or:

TRICHINOSIS

Disease severity is related particularly to:

The number of larvae ingested

Heavy infections generally produce more severe systemic manifestations.

Asymptomatic Infection

Many infections are:

Asymptomatic

especially when only a small number of larvae are ingested.

Intestinal Phase

Early symptoms result from maturation of adult worms in the intestine.

Possible manifestations include:

• Diarrhea

• Abdominal discomfort

• Nausea

• Vomiting

• Malaise

The source particularly notes:

Mild diarrhea

which may precede ocular and muscular manifestations.

Systemic and Muscular Phase

As larvae disseminate into tissues, patients may develop:

• Fever

• Diffuse myalgia

• Muscle weakness

• Periorbital edema

• Facial edema

• Headache

• Marked eosinophilia

This phase is the classic presentation of symptomatic trichinellosis.

Myalgia

One of the most characteristic manifestations is:

DIFFUSE MUSCLE PAIN

Muscle invasion by larvae produces inflammation, resulting in:

Myalgia + tenderness + weakness

Muscle Distribution

Larvae preferentially involve active striated muscles.

Commonly affected muscles can include:

• Extraocular muscles

• Masseter muscles

• Diaphragm

• Intercostal muscles

• Tongue

• Deltoids

• Gastrocnemius muscles

This muscle tropism explains many of the characteristic clinical findings.

Periorbital Edema

A particularly important diagnostic clue is:

EDEMA OF THE UPPER EYELIDS

or:

PERIORBITAL EDEMA

When this occurs with:

Fever + myalgia + eosinophilia

after eating undercooked pork or wild game, trichinellosis should be strongly considered.

Classic Clinical Pattern

Undercooked pork/wild game

• ●

Early diarrhea

↓

Several days later:

Fever

• ●

Periorbital edema

• ●

Diffuse myalgia

• ●

Marked eosinophilia

→ TRICHINELLA SPIRALIS

Eosinophilia

A major laboratory clue is:

MARKED EOSINOPHILIA

Eosinophilia develops in response to:

Tissue-invasive larval migration

and can be particularly prominent during systemic disease.

Cardiac Involvement

Severe infection may involve the:

HEART

Cardiac complications can include:

• Myocarditis

• Arrhythmias

• Heart failure in severe cases

Cardiac involvement represents:

Severe trichinellosis

and requires close medical management.

Central Nervous System Involvement

The:

CENTRAL NERVOUS SYSTEM

may also be affected in severe disease.

Possible manifestations include:

• Headache

• Confusion

• Meningoencephalitis

• Seizures

• Focal neurologic abnormalities

CNS involvement is an important marker of:

Severe systemic infection

Respiratory Involvement

Because larvae can affect respiratory muscles, severe infection may produce:

• Dyspnea

• Respiratory muscle weakness

Involvement of the diaphragm and other respiratory muscles can contribute to serious complications.

Diagnosis

The source lists:

• Serology

• Muscle biopsy

as important diagnostic approaches.

A major supportive laboratory finding is:

Marked eosinophilia

Serology

Serologic testing can demonstrate:

Antibodies against Trichinella

and is useful in patients with an appropriate clinical and exposure history.

Antibodies may not become detectable immediately after infection, so timing should be considered when interpreting early negative results.

Muscle Biopsy

A muscle biopsy may demonstrate:

Encysted larvae within skeletal muscle

This can provide direct parasitologic evidence of infection.

However, biopsy is generally reserved for situations in which diagnostic uncertainty remains.

Laboratory Findings

In addition to eosinophilia, muscle inflammation may produce increased:

Muscle enzymes

such as:

Creatine kinase (CK)

in symptomatic muscular disease.

Stool Examination

An important examination point is that routine stool examination is generally:

Not useful for diagnosing trichinellosis

because the characteristic tissue phase involves larvae migrating into:

Skeletal muscle

rather than eggs being routinely passed in human stool.

Treatment

The source recommends:

MEBENDAZOLE

or:

ALBENDAZOLE

particularly when treatment is initiated:

Early in infection

Why Early Treatment Matters

Anthelmintic treatment is most useful while adult worms and developing larvae remain susceptible before extensive tissue encystment has occurred.

Therefore:

Earlier therapy is generally more effective than treatment after larvae have become established in muscle.

Corticosteroids

The source notes that:

STEROIDS

may be required when severe inflammatory manifestations occur, particularly with:

• CNS involvement

• Cardiac involvement

Corticosteroids may also be considered in other severe systemic manifestations under appropriate medical supervision.

Severe Disease Treatment Pattern

Trichinellosis

• ●

CNS or cardiac involvement

→ Albendazole/mebendazole

• ●

Corticosteroid therapy when indicated

• ●

Supportive management

Prevention

The most important preventive measure is:

PROPER COOKING OF MEAT

This applies particularly to:

• Fresh pork

• Pork products

• Bear meat

• Wild boar

• Other wild-game meat

Important Food-Safety Pearl

Do not rely solely on:

Smoking, curing, drying, or other nonvalidated preparation methods

to eliminate Trichinella larvae from wild-game meat.

Appropriate cooking is the key preventive measure.

Trichinella vs. Toxocara

Both can cause:

Eosinophilia

but their exposure patterns differ.

Trichinella spiralis

→ Undercooked meat

→ Pork/wild game

→ Intestinal symptoms followed by myalgia

→ Periorbital edema

→ Larvae in skeletal muscle

Toxocara

→ Dog/cat feces in soil

→ Children/pica

→ Visceral larva migrans

→ Hepatomegaly and pulmonary symptoms

→ Ocular larva migrans

High-Yield Distinction

Eosinophilia + myalgia + periorbital edema + undercooked pork

→ Trichinella

Eosinophilia + hepatomegaly + child + dog/cat soil exposure

→ Toxocara

Trichinella vs. Taenia saginata

Trichinella spiralis

→ Pork or wild game

→ Nematode

→ Tissue-invasive larvae

→ Myalgia + periorbital edema + eosinophilia

Taenia saginata

→ Beef

→ Cestode

→ Adult intestinal tapeworm

→ Usually mild/asymptomatic GI disease

→ Proglottids/eggs in stool

Trichinella vs. Taenia solium

Both may be associated with pork, but the diseases are very different.

Trichinella spiralis

Undercooked pork containing larvae

→ Trichinellosis

→ Muscle invasion

→ Myalgia + periorbital edema + eosinophilia

Taenia solium

Undercooked pork containing cysticerci

→ Intestinal taeniasis

Ingestion of T. solium eggs

→ Cysticercosis/neurocysticercosis

High-Yield Clinical Pattern

Undercooked pork/bear/wild-boar meat

• ●

Early gastrointestinal symptoms

↓

5–45 days later

↓

Fever + diffuse myalgia + weakness

• ●

Upper-eyelid/periorbital edema

• ●

Marked eosinophilia

→ Think TRICHINELLA SPIRALIS

Exam Essentials

Genus: Trichinella

Species: T. spiralis

Organism: Nematode helminth

Disease: Trichinellosis / trichinosis

Distribution: Worldwide

Transmission: Consumption of raw or undercooked infected meat

Classic source: Pork

Other important sources: Bear and wild-boar meat

Infective stage: Encysted larvae in meat

Early symptoms: Gastrointestinal symptoms within several days

Systemic symptoms: Approximately 5–45 days after infection

Classic systemic manifestations: Myalgia + weakness + periorbital edema

Major laboratory clue: Marked eosinophilia

Major tissue involved: Striated skeletal muscle

Serious complications: Myocarditis and CNS disease

Diagnosis: Serology and, when necessary, muscle biopsy

Stool examination: Generally not useful

Treatment: Mebendazole or albendazole, especially early in infection

Severe CNS/cardiac disease: Corticosteroids may be required

Prevention: Thoroughly cook pork and wild-game meat

Memory Aid

TRICHINELLA = TRICHY TRIAD

Think:

PORK/WILD GAME

↓

MYALGIA

• ●

PERIORBITAL EDEMA

• ●

EOSINOPHILIA

→ TRICHINELLA SPIRALIS

Another useful sequence:

GUT → BLOOD → MUSCLE

Early diarrhea

→ Larval dissemination

→ Muscle pain and edema

Key clinical pearl: Trichinella spiralis is a foodborne nematode acquired from raw or inadequately cooked pork or wild-game meat. The classic progression is early gastrointestinal illness followed days to weeks later by fever, diffuse myalgia, muscle weakness, periorbital edema, and marked eosinophilia as larvae invade skeletal muscle. Severe infections may involve the heart or CNS. Serology is an important diagnostic method, albendazole or mebendazole is most useful when given early, and proper cooking of pork and wild-game meat is the key preventive measure.

Infectious Disease and Microbiology – Treponema carateum

Overview

Treponema carateum is a spirochete that causes pinta, a chronic, nonvenereal treponemal infection involving primarily the skin. The disease occurs mainly in tropical regions of the Americas, particularly parts of Central and South America.

Pinta is characterized by slowly evolving plaque-like skin lesions that may undergo striking changes in pigmentation over time. Unlike venereal syphilis, pinta is essentially a cutaneous disease and is not classically associated with cardiovascular, neurologic, or congenital complications.

Classification

Genus: Treponema

Species: Treponema carateum

Organism: Spirochete

Disease: Pinta

Pinta belongs to the group of:

Endemic nonvenereal treponematoses

Microbiologic Characteristics

T. carateum is a:

• Thin, spiral-shaped bacterium

• Spirochete

• Treponemal organism closely related to other pathogenic Treponema species

• Primarily cutaneous pathogen

Its morphology is very similar to other pathogenic treponemes.

High-Yield Microbiology Pattern

Spirochete

• ●

Tropical Americas

• ●

Chronic plaque-like skin lesions

• ●

Progressive pigmentary changes

→ Think TREPONEMA CARATEUM

Incubation Period

The usual incubation period is approximately:

2–3 weeks

After this period, the initial skin lesion develops at the site of infection.

Epidemiology

Pinta is primarily associated with:

Tropical regions of the Americas

The source particularly emphasizes:

South America

Historically, disease has occurred in rural communities where close interpersonal contact facilitates transmission.

Transmission

Unlike syphilis, pinta is:

NONVENEREAL

Transmission is believed to occur primarily through:

Direct skin-to-skin contact with an infected lesion

especially when minor breaks in the skin permit inoculation.

Pinta

The disease caused by T. carateum is:

PINTA

Pinta is predominantly a:

Chronic cutaneous treponematosis

The disease evolves through different stages, with lesions changing in appearance and pigmentation over time.

Primary Lesion

The initial lesion is typically a:

Papule or plaque

that gradually enlarges.

The source describes plaque-like lesions particularly involving the:

• Dorsum of the foot

• Legs

Other exposed areas of skin may also become involved.

Regional Lymphadenopathy

The primary skin lesion may be accompanied by:

Regional lymph node enlargement

reflecting the local infectious process.

Evolution of Skin Lesions

As the infection progresses, additional skin lesions may appear.

One of the most characteristic features is:

ALTERED SKIN PIGMENTATION

Lesions may initially become:

Hyperpigmented

and later develop areas of:

Hypopigmentation or depigmentation

High-Yield Clinical Pattern

Tropical American exposure

• ●

Chronic plaque-like lesions

• ●

Progressive hyperpigmentation/depigmentation

• ●

No major systemic disease

→ Think PINTA

Late Pinta

Chronic disease can produce persistent:

Pigmentary abnormalities

The skin may develop irregular areas of:

• Hyperpigmentation

• Hypopigmentation

• Depigmentation

• Atrophic change in some lesions

These late pigmentary changes are among the most recognizable features of pinta.

Systemic Involvement

An important distinction from syphilis is that pinta is primarily limited to the:

SKIN

It does not characteristically produce the severe:

• Neurologic

• Cardiovascular

• Visceral

• Congenital

manifestations associated with Treponema pallidum syphilis.

Diagnosis

Diagnosis is based on:

• Clinical presentation

• Epidemiologic history

• Treponemal and nontreponemal serology

• Direct demonstration of treponemes from active lesions

Nontreponemal Serologic Tests

The source lists:

Rapid Plasma Reagin (RPR)

and:

Venereal Disease Research Laboratory (VDRL)

testing.

These tests may become reactive in pinta.

Treponemal Serologic Tests

Treponemal tests may also be positive, including:

Treponema pallidum particle agglutination (TPPA)

Important Serology Pearl

Standard syphilis serologic tests generally:

Cannot reliably distinguish pinta from other treponemal infections

because the pathogenic treponemes are antigenically very similar.

Therefore, diagnosis depends on:

Clinical syndrome + epidemiology + serology

rather than serology alone.

Dark-Field Examination

The source also lists:

DARK-FIELD MICROSCOPY

Material obtained from an active lesion can be examined for:

Motile spirochetes

However, the organisms are morphologically difficult to distinguish from other pathogenic treponemes.

Diagnostic Pattern

Typical chronic pigmentary skin lesions

• ●

Residence/travel in endemic tropical Americas

• ●

Reactive treponemal serology

±

Spirochetes demonstrated in lesion material

→ Supports PINTA

Treatment

The source identifies:

BENZYL PENICILLIN

as the primary treatment.

Treponemal infections are generally highly susceptible to:

Penicillin

Additional Treatment

The source lists:

• Tetracycline

• Chloramphenicol

as additional therapeutic options.

Penicillin remains the classic treatment when appropriate.

Effect of Treatment

Antimicrobial treatment:

Eradicates the infection

and prevents further progression.

However, longstanding pigmentary changes may:

Resolve slowly or remain persistent

even after successful antimicrobial therapy.

Pinta vs. Syphilis vs. Yaws vs. Bejel

The endemic treponematoses are an important examination comparison.

Pinta

Organism: T. carateum

Distribution: Tropical Americas

Major manifestation: Pigmentary skin disease

Systemic disease: Minimal/absent

Yaws

Organism: T. pallidum subsp. pertenue

Distribution: Humid tropical regions

Major manifestations: Skin, soft tissue, and bone disease

Bejel

Organism: T. pallidum subsp. endemicum

Distribution: Traditionally arid regions

Major manifestations: Mucocutaneous and skeletal disease

Syphilis

Organism: T. pallidum subsp. pallidum

Transmission: Primarily sexual or vertical

Major manifestations: Multistage systemic disease with potential neurologic, cardiovascular, and congenital involvement

High-Yield Comparison

Pinta

→ Pigment

Yaws

→ Skin + bone

Bejel

→ Mucosa + bone

Syphilis

→ Sexual/systemic treponematosis

Prevention

Prevention focuses on:

• Early identification and treatment of infected individuals

• Reducing direct contact with active lesions

• Improving hygiene and living conditions in endemic communities

• Treating cases to interrupt community transmission

High-Yield Clinical Pattern

Tropical South/Central America

• ●

2–3 week incubation

• ●

Plaque-like lesion on extremity

• ●

Regional lymphadenopathy

• ●

Progressive pigmentary changes

→ Think TREPONEMA CARATEUM → PINTA

Exam Essentials

Genus: Treponema

Species: T. carateum

Organism: Spirochete

Disease: Pinta

Disease category: Nonvenereal endemic treponematosis

Incubation: Usually 2–3 weeks

Distribution: Primarily tropical Americas

Transmission: Primarily direct skin contact with infectious lesions

Major organ involved: Skin

Primary lesion: Papule/plaque, often involving the extremities

Lymph nodes: Regional lymphadenopathy may occur

Classic late feature: Hyperpigmentation followed by hypopigmentation/depigmentation

Major systemic complications: Generally absent

Diagnosis: Clinical/epidemiologic findings + RPR/VDRL and treponemal testing

Direct examination: Dark-field microscopy of active lesions

Serology pearl: Standard tests cannot reliably distinguish the different treponematoses

Classic treatment: Benzyl penicillin

Additional source treatments: Tetracycline or chloramphenicol

Memory Aid

PINTA = PAINTED SKIN

Think:

PINTA

→ PIGMENT

→ PAINTED appearance of the skin

And:

T. CARATEUM = CUTANEOUS TREPONEME

Tropical Americas + chronic pigment-changing skin plaques

→ T. carateum

Key clinical pearl: Treponema carateum is the spirochete responsible for pinta, a nonvenereal endemic treponematosis of tropical America characterized primarily by chronic plaque-like skin lesions that develop progressive hyperpigmentation and depigmentation. Treponemal and nontreponemal serologic tests may be reactive but cannot reliably distinguish pinta from other treponematoses, so the clinical and epidemiologic setting is essential. Penicillin is the classic treatment.

Infectious Disease and Microbiology – Toxocara Species

Overview

Toxocara species are nematode helminths that cause human toxocariasis, usually after ingestion of embryonated eggs from soil contaminated with dog or cat feces. The two major species are Toxocara canis from dogs and Toxocara cati from cats.

Humans are accidental hosts. The larvae migrate through tissues but do not normally mature into adult worms, producing syndromes such as visceral larva migrans and ocular larva migrans.

Classification

Genus: Toxocara

Important species:

• Toxocara canis — associated with dogs

• Toxocara cati — associated with cats

Organism: Nematode helminth

Human disease: Toxocariasis

Microbiologic Characteristics

Toxocara species are:

• Roundworms

• Nematode helminths

• Parasites of dogs and cats

• Transmitted to humans through ingestion of infective eggs

• Unable to complete their normal life cycle in humans

Humans therefore serve as:

Accidental/paratenic hosts

High-Yield Microbiology Pattern

Nematode

• ●

Dog or cat feces

• ●

Contaminated soil

• ●

Larval migration through human tissues

→ Think TOXOCARA

Transmission

The major route of infection is:

INGESTION OF EMBRYONATED EGGS

Eggs are shed in the feces of infected:

Dogs — T. canis

or

Cats — T. cati

After a period in the environment, the eggs become infective.

Soil Exposure

Humans typically acquire infection by ingesting:

Soil contaminated with dog or cat feces

Risk is increased by:

• Poor hand hygiene

• Playing in contaminated soil

• Geophagia or pica

• Exposure to contaminated sandboxes

• Close contact with infected puppies or kittens

Young Children

Young children are particularly susceptible because they are more likely to:

• Play directly in soil

• Put contaminated hands or objects in the mouth

• Practice geophagia or pica

• Have close contact with puppies or kittens

High-Yield Epidemiologic Pattern

Young child

• ●

Pica/soil exposure

• ●

Dogs or cats

• ●

Marked eosinophilia

→ Think Toxocara

Incubation Period

Clinical manifestations may develop:

Weeks to months after infection

However, ocular disease may become apparent much later.

The source notes that ocular manifestations may appear approximately:

2–10 years after initial infection

Life Cycle in Humans

After ingestion:

Embryonated egg

↓

Larva hatches in the intestine

↓

Penetrates intestinal wall

↓

Enters bloodstream

↓

Migrates through tissues

↓

Inflammatory and eosinophilic response develops

Because humans are accidental hosts:

Larvae do not mature into normal adult intestinal worms

Major Clinical Syndromes

The two classic forms are:

VISCERAL LARVA MIGRANS

and

OCULAR LARVA MIGRANS

Visceral Larva Migrans

Visceral larva migrans results from migration of larvae through internal organs.

Many infections are:

Mild or asymptomatic

but symptomatic disease may produce:

• Fever

• Malaise

• Hepatomegaly

• Abdominal symptoms

• Cough

• Wheezing

Hepatic Involvement

The liver is one of the most common organs involved.

Patients may develop:

Hepatomegaly

and occasionally abnormal liver-related findings.

The liver may contain inflammatory lesions around migrating larvae.

Pulmonary Involvement

Larval migration through the lungs can cause:

• Cough

• Wheezing

• Dyspnea

• Pulmonary infiltrates in some cases

The combination of:

Pulmonary symptoms + eosinophilia + dog/cat soil exposure

is highly suggestive of a tissue-migrating helminth such as Toxocara.

Eosinophilia

One of the most characteristic findings in visceral toxocariasis is:

MARKED EOSINOPHILIA

The source notes that eosinophil counts in heavy infection may rise dramatically, even to approximately:

80,000/mm³

High-Yield Visceral Pattern

Young child

• ●

Dog/cat exposure

• ●

Fever

• ●

Hepatomegaly

• ●

Cough/wheezing

• ●

Marked eosinophilia

→ Think VISCERAL LARVA MIGRANS due to Toxocara

Ocular Larva Migrans

When a larva migrates into the eye, the condition is called:

OCULAR LARVA MIGRANS

This form may occur years after initial infection.

Ocular Manifestations

Possible findings include:

• Reduced visual acuity

• Unilateral visual disturbance

• Retinal granuloma

• Uveitis

• Endophthalmitis-like inflammation

• Strabismus in some children

Ocular disease may cause significant permanent visual impairment if not recognized.

Important Ocular Pearl

Unlike visceral disease, ocular toxocariasis often does not produce the same degree of:

Marked peripheral eosinophilia

Therefore, a normal eosinophil count does not exclude:

Ocular larva migrans

CNS Disease

Rarely, larvae may migrate to the:

Central nervous system

producing neurologic toxocariasis.

Possible manifestations depend on the involved site and may include:

• Headache

• Seizures

• Focal neurologic findings

Diagnosis

Diagnosis is based primarily on:

• Clinical presentation

• Epidemiologic exposure

• Serologic testing such as ELISA

ELISA

Serologic testing by:

ELISA

can detect antibodies against Toxocara antigens and is an important diagnostic tool.

Interpretation should take into account:

Compatible clinical findings + exposure history

because antibodies can indicate previous exposure as well as active disease.

Tissue Biopsy

Direct visualization of larvae in:

Tissue biopsy

can establish a definitive diagnosis.

However, the source emphasizes that biopsy is:

Rarely indicated

because larvae are difficult to locate and diagnosis is usually made clinically and serologically.

Stool Examination

An important exam point is:

STOOL EXAMINATION IS NOT USEFUL FOR HUMAN TOXOCARIASIS

Why?

Because humans do not usually harbor:

Adult intestinal Toxocara worms

Therefore, humans do not typically pass:

Toxocara eggs in stool

High-Yield Diagnostic Pattern

Visceral symptoms

• ●

Marked eosinophilia

• ●

Dog/cat soil exposure

• ●

Positive Toxocara ELISA

→ TOXOCARIASIS

Treatment

Many infections are:

Mild and self-limited

Therefore, the source notes that:

No treatment is usually necessary

for uncomplicated mild disease.

Albendazole

For:

Heavy, symptomatic, or significant visceral infection

the source recommends:

ALBENDAZOLE

Albendazole is a commonly used antihelminthic agent for clinically important toxocariasis.

Ocular Disease

Suspected ocular involvement requires:

OPHTHALMOLOGY EVALUATION

because visual injury can become permanent.

Management may require individualized treatment directed at both:

The parasite

and

The inflammatory response within the eye

Why Ophthalmology Matters

In ocular toxocariasis, much of the damage may result from:

Host inflammatory response around the larva

Therefore, treatment decisions require careful ophthalmologic assessment to preserve vision.

Toxocara vs. Ascaris

Both are nematodes, but:

Toxocara

→ Dog/cat parasite

→ Humans are accidental hosts

→ Tissue larvae

→ Visceral/ocular larva migrans

→ Marked eosinophilia

→ No adult worms or eggs in human stool

Ascaris lumbricoides

→ Human intestinal nematode

→ Adults live in intestine

→ Eggs are passed in human stool

→ Pulmonary larval migration can occur

Toxocara vs. Ancylostoma braziliense

Both can produce larval migration in humans.

Toxocara

→ Visceral or ocular larva migrans

→ Internal organs/eye

→ Dog/cat fecal contamination

→ Often marked eosinophilia

Ancylostoma braziliense

→ Cutaneous larva migrans

→ Serpiginous pruritic skin tracks

→ Dog/cat hookworm larvae penetrate skin

Toxocara vs. Strongyloides

Toxocara

→ Acquired by ingesting eggs

→ Tissue migration

→ Humans do not develop adult intestinal egg-producing infection

→ Visceral/ocular larva migrans

Strongyloides

→ Infective larvae penetrate skin

→ Adult worms inhabit intestine

→ Autoinfection can occur

→ Hyperinfection in immunosuppression

Prevention

Prevention focuses on reducing exposure to infective eggs.

Important measures include:

• Regular veterinary deworming of dogs and cats

• Prompt disposal of pet feces

• Handwashing after soil or animal contact

• Preventing children from eating soil

• Covering sandboxes when not in use

• Washing produce contaminated with soil

• Preventing pets from defecating in children’s play areas

High-Yield Clinical Pattern

Young child

• ●

Soil ingestion/pica

• ●

Dog or cat exposure

• ●

Fever + hepatomegaly + cough/wheezing

• ●

Extreme eosinophilia

→ Think TOXOCARA → VISCERAL LARVA MIGRANS

High-Yield Ocular Pattern

Child or young person

• ●

Unilateral visual problem

• ●

Retinal granuloma

• ●

Remote dog/cat/soil exposure

→ Think OCULAR LARVA MIGRANS due to Toxocara

Exam Essentials

Genus: Toxocara

Species: T. canis and T. cati

Organism: Nematode helminth

Dog-associated species: T. canis

Cat-associated species: T. cati

Distribution: Worldwide

Transmission: Ingestion of embryonated eggs from soil contaminated with dog/cat feces

Major risk group: Young children, especially with pica/geophagia

Incubation: Weeks to months

Ocular disease latency: May appear 2–10 years later

Major syndrome: Visceral larva migrans

Classic visceral findings: Fever, malaise, hepatomegaly, cough, and wheezing

Major laboratory clue: Marked eosinophilia

Eye disease: Ocular larva migrans

Diagnosis: Clinical findings + ELISA

Definitive but rarely needed: Larva in tissue biopsy

Stool examination: Usually not diagnostic because humans do not harbor adult egg-producing worms

Mild infection: Often no treatment required

Heavy/symptomatic infection: Albendazole

Ocular involvement: Urgent ophthalmologic evaluation

Memory Aid

TOXOCARA = TODDLER + TOY SOIL + TOXIC EOSINOPHILIA

Think:

Toddler playing in contaminated soil

• ●

Dog/cat feces

• ●

Huge eosinophilia

• ●

Liver/lung symptoms

→ Toxocara

And:

CANIS = CANINE

T. canis → dogs

CATI = CAT

T. cati → cats

Key clinical pearl: Toxocara canis and T. cati cause toxocariasis when humans accidentally ingest embryonated eggs from soil contaminated with dog or cat feces. Children are especially vulnerable. Visceral larva migrans classically produces hepatomegaly, pulmonary symptoms, and striking eosinophilia, whereas ocular larva migrans may present years later with unilateral retinal disease and may occur without marked eosinophilia. Because humans harbor migrating larvae rather than adult intestinal worms, stool examination is not useful; diagnosis relies mainly on exposure history, clinical findings, and serology.

Infectious Disease and Microbiology – Taenia saginata

Overview

Taenia saginata is a cestode (tapeworm) that causes taeniasis, commonly called beef tapeworm infection. Humans become infected by eating raw or inadequately cooked beef containing larval cysts.

Most infections are asymptomatic, although some patients develop mild gastrointestinal complaints such as nausea, dyspepsia, abdominal discomfort, or altered appetite.

Classification

Genus: Taenia

Species: Taenia saginata

Organism type: Cestode helminth

Disease: Intestinal taeniasis / beef tapeworm infection

Microbiologic Characteristics

T. saginata is a:

• Segmented tapeworm

• Intestinal cestode

• Parasite acquired from infected cattle

• Helminth in which the adult worm lives in the human small intestine

Humans act as the:

Definitive host

while cattle act as the:

Intermediate host

High-Yield Microbiology Pattern

Cestode

• ●

Undercooked beef

• ●

Adult intestinal tapeworm

• ●

Proglottids or eggs in stool

→ Think TAENIA SAGINATA

Life Cycle

The life cycle involves:

Humans

and

Cattle

Human Stage

An infected human passes:

Eggs or gravid proglottids in stool

↓

Eggs contaminate the environment

↓

Cattle ingest the eggs

Cattle Stage

After ingestion by cattle:

Eggs hatch

↓

Larvae penetrate the intestinal wall

↓

Migrate to skeletal muscle

↓

Develop into:

Cysticerci

Human Infection

Humans become infected by eating:

Raw or insufficiently cooked beef containing viable cysticerci

↓

Cysticercus develops into adult tapeworm

↓

Adult worm attaches to small intestine

↓

Proglottids and eggs are eventually passed in stool

Incubation / Prepatent Period

The source states that eggs usually begin appearing in stool approximately:

10–14 weeks after infection

This corresponds to maturation of the adult tapeworm in the intestine.

Epidemiology

T. saginata has a:

Worldwide distribution

It is more common in areas where:

• Beef is eaten raw or undercooked

• Meat inspection is inadequate

• Human fecal contamination of cattle environments occurs

• Sanitation is limited

Transmission

The major route is:

UNDERCOOKED BEEF

The infective stage for humans is the:

Cysticercus larva in beef muscle

High-Yield Transmission Pattern

Raw/undercooked beef

↓

Cysticercus ingestion

↓

Adult intestinal tapeworm

↓

Taeniasis

Clinical Infection

The disease is called:

TAENIASIS

Most infections are:

Asymptomatic

Gastrointestinal Symptoms

When symptoms occur, they are usually mild and may include:

• Dyspepsia

• Nausea

• Abdominal discomfort

• Altered appetite

• Diarrhea or constipation

• Weight loss in some patients

Passage of Proglottids

A particularly characteristic complaint is:

Passage of motile tapeworm segments in stool or around the anus

Patients may notice moving:

Proglottids

which can be alarming despite otherwise mild disease.

Diagnosis

The main diagnostic method is:

PARASITOLOGIC EXAMINATION OF STOOL

Stool microscopy may demonstrate:

• Taenia eggs

• Proglottids

Egg Morphology

Taenia eggs are typically:

• Round to oval

• Thick-walled

• Radially striated

• Contain an oncosphere with hooklets

However, an important exam point is:

Eggs of T. saginata and T. solium are morphologically indistinguishable.

Species identification therefore requires examination of:

Proglottids or scolex morphology

or molecular methods.

Proglottid Identification

Gravid proglottids of T. saginata characteristically have:

More numerous lateral uterine branches

than those of T. solium.

A classic comparison is:

T. saginata

→ approximately 15–30 uterine branches per side

T. solium

→ approximately 7–13 uterine branches per side

Scolex Morphology

T. saginata has an:

Unarmed scolex

with:

• Four suckers

• No rostellum with hooks

This contrasts with T. solium, which has an:

Armed scolex with hooks

High-Yield Species Distinction

Taenia saginata

Beef

• ●

Unarmed scolex

• ●

More uterine branches

→ T. saginata

Taenia solium

Pork

• ●

Armed scolex

• ●

Fewer uterine branches

→ T. solium

Treatment

The primary treatment is:

PRAZIQUANTEL

Praziquantel is highly effective against intestinal Taenia infection.

Additional Treatment

The source lists:

Niclosamide

as an alternative treatment.

Follow-Up

After treatment, follow-up stool examination may be used to confirm:

Parasite clearance

especially when there is concern for persistent infection.

Prevention

The key preventive measure is:

THOROUGH COOKING OF BEEF

Other useful preventive measures include:

• Proper meat inspection

• Improved sanitation

• Preventing cattle access to human fecal contamination

• Appropriate food handling

• Avoiding raw or inadequately cooked beef

Taenia saginata vs. Taenia solium

This is the most important comparison.

Taenia saginata

→ Beef tapeworm

→ Cattle intermediate host

→ Human infection from beef cysticerci

→ Adult intestinal infection

→ Does not classically cause human cysticercosis

Taenia solium

→ Pork tapeworm

→ Pig intermediate host

→ Human intestinal infection from pork cysticerci

→ Ingestion of eggs can cause cysticercosis/neurocysticercosis

High-Yield Safety Distinction

Eating undercooked pork containing cysticerci

→ Intestinal T. solium taeniasis

Ingesting T. solium eggs

→ Cysticercosis

By contrast:

T. saginata causes intestinal beef tapeworm infection and is not the classic cause of cysticercosis in humans.

Taenia saginata vs. Diphyllobothrium

Both cause adult intestinal tapeworm infections, but:

T. saginata

→ Beef

→ Cattle

→ Taenia eggs/proglottids

→ Usually mild GI symptoms

Diphyllobothrium/Dibothriocephalus

→ Freshwater fish

→ Operculated eggs

→ May cause vitamin B12 deficiency

High-Yield Clinical Pattern

History of eating undercooked beef

• ●

Minimal or mild GI symptoms

• ●

Motile proglottids in stool

• ●

Taenia eggs

→ Think TAENIA SAGINATA

Exam Essentials

Genus: Taenia

Species: T. saginata

Common name: Beef tapeworm

Organism: Cestode helminth

Human role: Definitive host

Intermediate host: Cattle

Infective stage for humans: Cysticercus in beef

Transmission: Raw or undercooked beef

Distribution: Worldwide

Egg appearance in stool: Approximately 10–14 weeks after infection

Disease: Taeniasis

Typical symptoms: Usually asymptomatic; mild dyspepsia, nausea, or abdominal discomfort may occur

Characteristic clue: Passage of motile proglottids

Diagnosis: Stool parasitology

Eggs: Indistinguishable from T. solium eggs

Scolex: Unarmed

Gravid proglottid: More uterine branches than T. solium

Treatment: Praziquantel

Alternative: Niclosamide

Prevention: Thorough cooking of beef

Major distinction from T. solium: T. saginata does not classically cause human cysticercosis

Memory Aid

SAGINATA = STEAK

T. saginata

→ Steak/beef

→ Suckers but no hooks

→ Segments in stool

And:

SAGINATA = SAFE FROM CYSTICERCOSIS

The major human cysticercosis risk belongs to:

T. solium

not T. saginata.

Key clinical pearl: Taenia saginata is the beef tapeworm. Humans acquire intestinal taeniasis by eating raw or undercooked beef containing cysticerci, and eggs or proglottids typically appear in stool after roughly 10–14 weeks. Infection is usually asymptomatic or causes only mild gastrointestinal symptoms. Diagnosis is made by stool parasitology, praziquantel is the classic treatment, and prevention depends primarily on thorough cooking of beef.

Infectious Disease and Microbiology – Streptococcus pyogenes (Group A β-Hemolytic Streptococcus)

Overview

Streptococcus pyogenes, also called Group A Streptococcus (GAS), is a Gram-positive coccus and one of the most important human streptococcal pathogens. It causes a wide spectrum of disease ranging from pharyngitis and impetigo to severe invasive infections such as necrotizing fasciitis, bacteremia, and streptococcal toxic shock syndrome.

It can also trigger important immune-mediated complications, particularly acute rheumatic fever and poststreptococcal glomerulonephritis.

Classification

Genus: Streptococcus

Species: Streptococcus pyogenes

Lancefield group: Group A

Common name:

Group A Streptococcus (GAS)

Microbiologic Characteristics

S. pyogenes is:

• Gram-positive coccus

• Catalase negative

• Usually arranged in chains

• Facultatively anaerobic

• β-hemolytic on blood agar

• Lancefield Group A

A major virulence factor is:

M protein

which helps the organism resist phagocytosis and is also important in strain classification.

High-Yield Microbiology Pattern

Gram-positive cocci in chains

• ●

Catalase negative

• ●

β-hemolytic

• ●

Group A

→ Think STREPTOCOCCUS PYOGENES

Incubation Period

For streptococcal pharyngitis, the incubation period is approximately:

2–5 days

For impetigo, the source describes approximately:

7–10 days

between acquisition of the organism on intact skin and development of lesions.

Epidemiology

S. pyogenes has a:

Worldwide distribution

Humans are the major reservoir.

Transmission commonly occurs through:

• Respiratory droplets

• Direct contact with infected respiratory secretions

• Direct contact with infected skin lesions

Streptococcal Pharyngitis

One of the most common infections is:

STREPTOCOCCAL PHARYNGITIS

Typical features include:

• Sudden sore throat

• Fever

• Tonsillar erythema

• Tonsillar exudates

• Tender anterior cervical lymphadenopathy

• Headache

• Abdominal symptoms in some children

Cough and rhinorrhea are less characteristic and suggest a viral cause.

High-Yield Pharyngitis Pattern

Fever

• ●

Exudative tonsillitis

• ●

Tender anterior cervical nodes

• ●

No cough

→ Think S. pyogenes

Scarlet Fever

Certain strains produce:

Pyrogenic exotoxins

that can cause:

SCARLET FEVER

This syndrome includes:

• Streptococcal pharyngitis

• Diffuse erythematous rash

• Fine “sandpaper” texture

• Strawberry tongue

• Pastia lines

The rash is toxin mediated.

Otitis and Sinusitis

S. pyogenes can occasionally cause:

• Otitis media

• Sinusitis

although other bacterial species are more common causes of these infections.

Pneumonia

GAS can cause:

Pneumonia

which may occasionally be severe and invasive, particularly when associated with bacteremia or toxin production.

Skin and Soft-Tissue Infections

S. pyogenes causes several important skin and soft-tissue syndromes:

• Impetigo

• Erysipelas

• Cellulitis

• Necrotizing fasciitis

Impetigo

Streptococcal impetigo is a superficial skin infection characterized by:

Vesicles/pustules → rupture → honey-colored crusts

It commonly affects children and exposed skin.

Erysipelas

Erysipelas is a more superficial infection involving:

Upper dermis and superficial lymphatics

It characteristically produces:

Bright red, raised, sharply demarcated skin inflammation

Cellulitis

Cellulitis involves:

Deeper dermis and subcutaneous tissues

Typical features include:

• Erythema

• Warmth

• Tenderness

• Swelling

The borders are generally less sharply demarcated than in erysipelas.

Necrotizing Fasciitis

One of the most severe manifestations is:

NECROTIZING FASCIITIS

This is a rapidly progressive infection of:

Deep fascia and surrounding soft tissue

Clinical Clues to Necrotizing Fasciitis

Important warning signs include:

• Severe pain out of proportion to examination

• Rapid progression

• Marked swelling

• Skin discoloration

• Bullae

• Systemic toxicity

• Hypotension

This is a:

SURGICAL EMERGENCY

Streptococcal Toxic Shock Syndrome

S. pyogenes can cause:

STREPTOCOCCAL TOXIC SHOCK SYNDROME

This is typically associated with invasive GAS infection and toxin production.

Clinical manifestations include:

Hypotension + multiorgan dysfunction + severe invasive infection

Superantigens

Streptococcal pyrogenic exotoxins can act as:

SUPERANTIGENS

causing massive nonspecific T-cell activation and release of inflammatory cytokines.

This contributes to:

Toxic shock syndrome

and:

Scarlet fever

Bacteremia

GAS can cause:

BACTEREMIA

particularly in association with:

• Severe skin and soft-tissue infection

• Necrotizing fasciitis

• Pneumonia

• Other invasive disease

Acute Rheumatic Fever

An important delayed immune-mediated complication is:

ACUTE RHEUMATIC FEVER

It follows:

Untreated or inadequately treated GAS pharyngitis

It does not classically follow impetigo.

Major Features of Rheumatic Fever

The classic Jones manifestations include:

• Migratory polyarthritis

• Carditis

• Sydenham chorea

• Erythema marginatum

• Subcutaneous nodules

High-Yield Rheumatic Fever Pattern

Recent GAS pharyngitis

• ●

Migratory polyarthritis

• ●

Carditis

±

Chorea

→ Think ACUTE RHEUMATIC FEVER

Poststreptococcal Glomerulonephritis

Another major delayed complication is:

POSTSTREPTOCOCCAL GLOMERULONEPHRITIS

Unlike rheumatic fever, it may follow:

Pharyngitis OR impetigo

Typical Features

• Hematuria

• Cola- or tea-colored urine

• Edema

• Hypertension

• Reduced complement, especially C3

High-Yield PSGN Pattern

Recent strep throat or impetigo

• ●

Dark urine

• ●

Edema

• ●

Hypertension

→ Think POSTSTREPTOCOCCAL GLOMERULONEPHRITIS

Erythema Nodosum

The source also lists:

Erythema nodosum

as an immune-associated complication that may follow streptococcal infection.

It presents with:

Tender erythematous subcutaneous nodules, often on the anterior shins.

Diagnosis

The source lists:

• Culture

• Serology

as diagnostic methods.

Throat Culture

For suspected streptococcal pharyngitis:

Throat culture

remains an important diagnostic method.

Rapid antigen detection and molecular tests may also be used in practice.

Serology

Antistreptococcal antibody testing can help establish evidence of a:

Recent GAS infection

especially when evaluating delayed complications.

Important antibodies include:

• Antistreptolysin O (ASO)

• Anti-DNase B

ASO Titer

ASO titers are particularly useful after:

Streptococcal pharyngitis

but may be less sensitive following skin infection.

Anti-DNase B

Anti-DNase B can be particularly useful when evaluating:

Poststreptococcal disease after impetigo

Treatment

The source lists:

PENICILLIN G

as a primary treatment.

Penicillin remains a classic treatment because S. pyogenes has remained highly susceptible to penicillin.

Amoxicillin

Amoxicillin is commonly used for:

Uncomplicated streptococcal pharyngitis

because of convenient oral dosing.

Clindamycin

Clindamycin is especially important in severe invasive GAS disease because it:

• Inhibits bacterial protein synthesis

• Reduces toxin production

• Remains useful even when bacterial burden is high

This is particularly relevant in:

Necrotizing fasciitis and streptococcal toxic shock syndrome

High-Yield Severe GAS Treatment Principle

Necrotizing fasciitis / streptococcal toxic shock

→ Penicillin + clindamycin

• ●

Urgent surgical debridement

Macrolides

The source lists:

Macrolide antibiotics

as additional options.

However, macrolide resistance occurs, so their use should be guided by:

Local susceptibility patterns and patient allergy history

Surgical Management

For necrotizing fasciitis:

ANTIBIOTICS ALONE ARE NOT ENOUGH

Urgent:

Surgical exploration and debridement

is essential.

Delays increase mortality.

Prevention of Rheumatic Fever

Appropriate treatment of GAS pharyngitis reduces the risk of:

Acute rheumatic fever

This is one of the main reasons to identify and treat confirmed streptococcal pharyngitis.

Important Limitation

Treating GAS infection does not reliably prevent:

Poststreptococcal glomerulonephritis

even though treatment is still indicated for the active infection.

Streptococcus pyogenes vs. Streptococcus agalactiae

S. pyogenes

→ Group A

→ β-hemolytic

→ Pharyngitis

→ Impetigo

→ Scarlet fever

→ Necrotizing fasciitis

→ Rheumatic fever

S. agalactiae

→ Group B

→ β-hemolytic

→ CAMP positive

→ Neonatal sepsis and meningitis

→ Maternal genital colonization

High-Yield Comparison

Group A = S. pyogenes

Group B = S. agalactiae

Streptococcus pyogenes vs. Staphylococcus aureus

Both can cause:

Skin and soft-tissue infections

but classic patterns differ.

S. pyogenes

→ Cellulitis

→ Erysipelas

→ Necrotizing fasciitis

→ More diffuse spreading infection

S. aureus

→ Abscesses

→ Furuncles

→ Carbuncles

→ Purulent focal infection

High-Yield Distinction

Spreading cellulitis/erysipelas

→ Think S. pyogenes

Purulent abscess

→ Think S. aureus

Prevention

Important preventive strategies include:

• Hand hygiene

• Respiratory hygiene

• Avoiding direct contact with infected skin lesions

• Prompt diagnosis and treatment of GAS pharyngitis

• Appropriate wound care

• Infection-control precautions for invasive disease

High-Yield Clinical Pattern

2–5 days after exposure

• ●

Fever + exudative pharyngitis

• ●

Tender anterior cervical nodes

• ●

β-hemolytic Group A Streptococcus

→ Think STREPTOCOCCUS PYOGENES

High-Yield Invasive Pattern

Rapidly progressive soft-tissue infection

• ●

Severe pain out of proportion

• ●

Systemic toxicity

• ●

Hypotension

→ Think S. pyogenes necrotizing fasciitis ± toxic shock syndrome

Exam Essentials

Genus: Streptococcus

Species: S. pyogenes

Lancefield group: A

Common name: Group A Streptococcus (GAS)

Organism: Gram-positive coccus

Arrangement: Chains

Catalase: Negative

Hemolysis: β-hemolytic

Distribution: Worldwide

Pharyngitis incubation: 2–5 days

Impetigo development after acquisition: Approximately 7–10 days

Major infections: Tonsillitis/pharyngitis, scarlet fever, impetigo, erysipelas, cellulitis, pneumonia, bacteremia, necrotizing fasciitis, and toxic shock syndrome

Major virulence factor: M protein

Toxin effect: Superantigen-mediated scarlet fever and toxic shock

Major immune complications: Acute rheumatic fever and poststreptococcal glomerulonephritis

Rheumatic fever follows: Pharyngitis

PSGN can follow: Pharyngitis or impetigo

Diagnosis: Culture, rapid antigen/molecular testing, and serology for prior infection

Important serology: ASO and anti-DNase B

Classic treatment: Penicillin

Oral pharyngitis option: Amoxicillin

Severe invasive disease: Penicillin + clindamycin + urgent source control/debridement

Additional source treatment: Macrolide antibiotics when appropriate

Memory Aid

PYOGENES = PUS + PHARYNX + POST-STREP COMPLICATIONS

P = Pharyngitis

Y = “Why is the skin spreading?” → cellulitis/erysipelas

O = Organ-invasive disease

G = Glomerulonephritis

E = Erysipelas

N = Necrotizing fasciitis

E = Exotoxins

S = Scarlet fever / Shock

Key clinical pearl: Streptococcus pyogenes is Group A β-hemolytic Streptococcus, a catalase-negative Gram-positive coccus that classically causes pharyngitis, impetigo, erysipelas, cellulitis, scarlet fever, and invasive necrotizing soft-tissue infection. The two major delayed immune complications are acute rheumatic fever, which follows pharyngitis, and poststreptococcal glomerulonephritis, which can follow either pharyngitis or impetigo. Severe invasive GAS disease requires rapid recognition, penicillin plus toxin-suppressing clindamycin, and urgent surgical debridement when necrotizing fasciitis is present.

Classification Genus: Streptococcus

Species: Streptococcus pyogenes

Lancefield group: Group A Common name: Group A Streptococcus (GAS)

Microbiologic Characteristics S. pyogenes is: • Gram-positive coccus

• Catalase negative

• Usually arranged in chains

• Facultatively anaerobic

• β-hemolytic on blood agar

• Lancefield Group A A major virulence factor is: M protein which helps the organism resist phagocytosis and is also important in strain classification.

High-Yield Microbiology Pattern Gram-positive cocci in chains  ●  Catalase negative  ●  β-hemolytic  ●  Group A → Think STREPTOCOCCUS PYOGENES

Incubation Period For streptococcal pharyngitis, the incubation period is approximately: 2–5 days For impetigo, the source describes approximately: 7–10 days between acquisition of the organism on intact skin and development of lesions.

Epidemiology S. pyogenes has a: Worldwide distribution Humans are the major reservoir. Transmission commonly occurs through: • Respiratory droplets

• Direct contact with infected respiratory secretions

• Direct contact with infected skin lesions

Streptococcal Pharyngitis One of the most common infections is: STREPTOCOCCAL PHARYNGITIS Typical features include: • Sudden sore throat

• Fever

• Tonsillar erythema

• Tonsillar exudates

• Tender anterior cervical lymphadenopathy

• Headache

• Abdominal symptoms in some children Cough and rhinorrhea are less characteristic and suggest a viral cause.

High-Yield Pharyngitis Pattern Fever  ●  Exudative tonsillitis  ●  Tender anterior cervical nodes  ●  No cough → Think S. pyogenes

Scarlet Fever Certain strains produce: Pyrogenic exotoxins that can cause: SCARLET FEVER This syndrome includes: • Streptococcal pharyngitis

• Diffuse erythematous rash

• Fine “sandpaper” texture

• Strawberry tongue

• Pastia lines The rash is toxin mediated.

Otitis and Sinusitis S. pyogenes can occasionally cause: • Otitis media

• Sinusitis although other bacterial species are more common causes of these infections.

Pneumonia GAS can cause: Pneumonia which may occasionally be severe and invasive, particularly when associated with bacteremia or toxin production.

Skin and Soft-Tissue Infections S. pyogenes causes several important skin and soft-tissue syndromes: • Impetigo

• Erysipelas

• Cellulitis

• Necrotizing fasciitis

Impetigo Streptococcal impetigo is a superficial skin infection characterized by: Vesicles/pustules → rupture → honey-colored crusts It commonly affects children and exposed skin.

Erysipelas Erysipelas is a more superficial infection involving: Upper dermis and superficial lymphatics It characteristically produces: Bright red, raised, sharply demarcated skin inflammation

Cellulitis Cellulitis involves: Deeper dermis and subcutaneous tissues Typical features include: • Erythema

• Warmth

• Tenderness

• Swelling The borders are generally less sharply demarcated than in erysipelas.

Necrotizing Fasciitis One of the most severe manifestations is: NECROTIZING FASCIITIS This is a rapidly progressive infection of: Deep fascia and surrounding soft tissue

Clinical Clues to Necrotizing Fasciitis Important warning signs include: • Severe pain out of proportion to examination

• Rapid progression

• Marked swelling

• Skin discoloration

• Bullae

• Systemic toxicity

• Hypotension This is a: SURGICAL EMERGENCY

Streptococcal Toxic Shock Syndrome S. pyogenes can cause: STREPTOCOCCAL TOXIC SHOCK SYNDROME This is typically associated with invasive GAS infection and toxin production. Clinical manifestations include: Hypotension + multiorgan dysfunction + severe invasive infection

Superantigens Streptococcal pyrogenic exotoxins can act as: SUPERANTIGENS causing massive nonspecific T-cell activation and release of inflammatory cytokines. This contributes to: Toxic shock syndrome and: Scarlet fever

Bacteremia GAS can cause: BACTEREMIA particularly in association with: • Severe skin and soft-tissue infection

• Necrotizing fasciitis

• Pneumonia

• Other invasive disease

Acute Rheumatic Fever An important delayed immune-mediated complication is: ACUTE RHEUMATIC FEVER It follows: Untreated or inadequately treated GAS pharyngitis It does not classically follow impetigo.

Major Features of Rheumatic Fever The classic Jones manifestations include: • Migratory polyarthritis

• Carditis

• Sydenham chorea

• Erythema marginatum

• Subcutaneous nodules

High-Yield Rheumatic Fever Pattern Recent GAS pharyngitis  ●  Migratory polyarthritis  ●  Carditis ± Chorea → Think ACUTE RHEUMATIC FEVER

Poststreptococcal Glomerulonephritis Another major delayed complication is: POSTSTREPTOCOCCAL GLOMERULONEPHRITIS Unlike rheumatic fever, it may follow: Pharyngitis OR impetigo

Typical Features • Hematuria

• Cola- or tea-colored urine

• Edema

• Hypertension

• Reduced complement, especially C3

High-Yield PSGN Pattern Recent strep throat or impetigo  ●  Dark urine  ●  Edema  ●  Hypertension → Think POSTSTREPTOCOCCAL GLOMERULONEPHRITIS

Erythema Nodosum The source also lists: Erythema nodosum as an immune-associated complication that may follow streptococcal infection. It presents with: Tender erythematous subcutaneous nodules, often on the anterior shins.

Diagnosis The source lists: • Culture

• Serology as diagnostic methods.

Throat Culture For suspected streptococcal pharyngitis: Throat culture remains an important diagnostic method. Rapid antigen detection and molecular tests may also be used in practice.

Serology Antistreptococcal antibody testing can help establish evidence of a: Recent GAS infection especially when evaluating delayed complications. Important antibodies include: • Antistreptolysin O (ASO)

• Anti-DNase B

ASO Titer ASO titers are particularly useful after: Streptococcal pharyngitis but may be less sensitive following skin infection.

Anti-DNase B Anti-DNase B can be particularly useful when evaluating: Poststreptococcal disease after impetigo

Treatment The source lists: PENICILLIN G as a primary treatment. Penicillin remains a classic treatment because S. pyogenes has remained highly susceptible to penicillin.

Amoxicillin Amoxicillin is commonly used for: Uncomplicated streptococcal pharyngitis because of convenient oral dosing.

Clindamycin Clindamycin is especially important in severe invasive GAS disease because it: • Inhibits bacterial protein synthesis

• Reduces toxin production

• Remains useful even when bacterial burden is high This is particularly relevant in: Necrotizing fasciitis and streptococcal toxic shock syndrome

High-Yield Severe GAS Treatment Principle Necrotizing fasciitis / streptococcal toxic shock → Penicillin + clindamycin  ●  Urgent surgical debridement

Macrolides The source lists: Macrolide antibiotics as additional options. However, macrolide resistance occurs, so their use should be guided by: Local susceptibility patterns and patient allergy history

Surgical Management For necrotizing fasciitis: ANTIBIOTICS ALONE ARE NOT ENOUGH Urgent: Surgical exploration and debridement is essential. Delays increase mortality.

Prevention of Rheumatic Fever Appropriate treatment of GAS pharyngitis reduces the risk of: Acute rheumatic fever This is one of the main reasons to identify and treat confirmed streptococcal pharyngitis.

Important Limitation Treating GAS infection does not reliably prevent: Poststreptococcal glomerulonephritis even though treatment is still indicated for the active infection.

Streptococcus pyogenes vs. Streptococcus agalactiae S. pyogenes → Group A

→ β-hemolytic

→ Pharyngitis

→ Impetigo

→ Scarlet fever

→ Necrotizing fasciitis

→ Rheumatic fever S. agalactiae → Group B

→ β-hemolytic

→ CAMP positive

→ Neonatal sepsis and meningitis

→ Maternal genital colonization

High-Yield Comparison Group A = S. pyogenes Group B = S. agalactiae

Streptococcus pyogenes vs. Staphylococcus aureus Both can cause: Skin and soft-tissue infections but classic patterns differ. S. pyogenes → Cellulitis

→ Erysipelas

→ Necrotizing fasciitis

→ More diffuse spreading infection S. aureus → Abscesses

→ Furuncles

→ Carbuncles

→ Purulent focal infection

High-Yield Distinction Spreading cellulitis/erysipelas → Think S. pyogenes Purulent abscess → Think S. aureus

Prevention Important preventive strategies include: • Hand hygiene

• Respiratory hygiene

• Avoiding direct contact with infected skin lesions

• Prompt diagnosis and treatment of GAS pharyngitis

• Appropriate wound care

• Infection-control precautions for invasive disease

High-Yield Clinical Pattern 2–5 days after exposure  ●  Fever + exudative pharyngitis  ●  Tender anterior cervical nodes  ●  β-hemolytic Group A Streptococcus → Think STREPTOCOCCUS PYOGENES

High-Yield Invasive Pattern Rapidly progressive soft-tissue infection  ●  Severe pain out of proportion  ●  Systemic toxicity  ●  Hypotension → Think S. pyogenes necrotizing fasciitis ± toxic shock syndrome

Exam Essentials Genus: Streptococcus

Species: S. pyogenes

Lancefield group: A

Common name: Group A Streptococcus (GAS)

Organism: Gram-positive coccus

Arrangement: Chains

Catalase: Negative

Hemolysis: β-hemolytic

Distribution: Worldwide

Pharyngitis incubation: 2–5 days

Impetigo development after acquisition: Approximately 7–10 days

Major infections: Tonsillitis/pharyngitis, scarlet fever, impetigo, erysipelas, cellulitis, pneumonia, bacteremia, necrotizing fasciitis, and toxic shock syndrome

Major virulence factor: M protein

Toxin effect: Superantigen-mediated scarlet fever and toxic shock

Major immune complications: Acute rheumatic fever and poststreptococcal glomerulonephritis

Rheumatic fever follows: Pharyngitis

PSGN can follow: Pharyngitis or impetigo

Diagnosis: Culture, rapid antigen/molecular testing, and serology for prior infection

Important serology: ASO and anti-DNase B

Classic treatment: Penicillin

Oral pharyngitis option: Amoxicillin

Severe invasive disease: Penicillin + clindamycin + urgent source control/debridement

Additional source treatment: Macrolide antibiotics when appropriate

Memory Aid PYOGENES = PUS + PHARYNX + POST-STREP COMPLICATIONS P = Pharyngitis

Y = “Why is the skin spreading?” → cellulitis/erysipelas

O = Organ-invasive disease

G = Glomerulonephritis

E = Erysipelas

N = Necrotizing fasciitis

E = Exotoxins

S = Scarlet fever / Shock

Key clinical pearl: Streptococcus pyogenes is Group A β-hemolytic Streptococcus, a catalase-negative Gram-positive coccus that classically causes pharyngitis, impetigo, erysipelas, cellulitis, scarlet fever, and invasive necrotizing soft-tissue infection. The two major delayed immune complications are acute rheumatic fever, which follows pharyngitis, and poststreptococcal glomerulonephritis, which can follow either pharyngitis or impetigo. Severe invasive GAS disease requires rapid recognition, penicillin plus toxin-suppressing clindamycin, and urgent surgical debridement when necrotizing fasciitis is present.

Infectious Disease and Microbiology – Streptococcus agalactiae (Group B Streptococcus)

Overview

Streptococcus agalactiae, commonly called Group B Streptococcus (GBS), is a Gram-positive coccus and an important cause of neonatal sepsis and meningitis. It commonly colonizes the gastrointestinal and female genital tracts, allowing maternal transmission to the newborn around the time of delivery.

GBS is also an important cause of urinary tract infection, bacteriuria, chorioamnionitis, and postpartum endometritis in pregnant patients. In addition, invasive GBS disease is increasingly recognized in nonpregnant adults, particularly older adults and those with significant underlying illnesses.

Classification

Genus: Streptococcus

Species: Streptococcus agalactiae

Lancefield group: Group B

Common abbreviation:

GBS

Microbiologic Characteristics

S. agalactiae is a:

• Gram-positive coccus

• Facultatively anaerobic organism

• Catalase-negative bacterium

• Usually β-hemolytic

• Organism arranged in chains or pairs

• Encapsulated bacterium

The polysaccharide capsule is an important:

Virulence factor

because it helps the organism resist:

Phagocytosis and host immune clearance

High-Yield Microbiology Pattern

Gram-positive cocci in chains

• ●

Catalase negative

• ●

β-hemolytic

• ●

Group B

→ Think Streptococcus agalactiae

Laboratory Identification

Classic laboratory characteristics include:

CAMP positive

and:

Hippurate positive

S. agalactiae is also classically resistant to:

Bacitracin

which helps distinguish it from Group A Streptococcus in traditional laboratory identification.

CAMP Test

The:

CAMP TEST

is a classic microbiology examination clue for GBS.

S. agalactiae produces CAMP factor, which enhances the hemolysis produced by Staphylococcus aureus.

Therefore:

CAMP-positive β-hemolytic Streptococcus

→ S. agalactiae

Epidemiology

S. agalactiae has a:

Worldwide distribution

The organism commonly colonizes the:

• Gastrointestinal tract

• Rectum

• Vagina

• Genitourinary tract

Colonization is frequently:

Asymptomatic

Maternal Colonization

Maternal rectovaginal colonization is particularly important because the organism can be transmitted to the infant:

During labor and delivery

This provides the major pathway leading to:

Early-onset neonatal GBS disease

Neonatal Group B Streptococcal Disease

GBS is a major cause of serious bacterial infection in:

NEWBORNS

Neonatal disease is traditionally divided into:

Early-onset disease

and

Late-onset disease

Early-Onset Neonatal Disease

Early-onset disease develops during approximately the:

First 6 days of life

and often begins within the:

First 24 hours after birth

The major mechanism is:

Maternal colonization

↓

Exposure during labor/delivery

↓

Neonatal colonization

↓

Invasive infection

Early-Onset Clinical Manifestations

The major manifestations include:

• Sepsis

• Pneumonia

• Respiratory distress

• Bacteremia

• Meningitis

Sepsis and pneumonia are particularly characteristic of:

Early-onset disease

High-Yield Early-Onset Pattern

Newborn

• ●

First hours/days of life

• ●

Respiratory distress

• ●

Sepsis ± pneumonia

• ●

Maternal GBS colonization

→ Think S. agalactiae

Risk Factors for Early-Onset Disease

Important risk factors include:

• Maternal GBS colonization

• Previous infant with invasive GBS disease

• GBS bacteriuria during pregnancy

• Preterm delivery

• Prolonged rupture of membranes

• Maternal intrapartum fever

These factors increase the probability of:

Vertical transmission and neonatal invasive disease

Late-Onset Neonatal Disease

Late-onset GBS disease generally occurs after the first several days of life and during the:

First few months of infancy

Unlike early disease, transmission may be:

Maternal or environmental

Late-Onset Clinical Manifestations

An especially important manifestation is:

MENINGITIS

Late-onset disease may also cause:

• Bacteremia

• Sepsis

• Bone and joint infection

• Other focal infections

High-Yield Neonatal Distinction

Early-onset GBS

Birth–6 days

→ Maternal vertical transmission

→ Sepsis + pneumonia

Late-onset GBS

After the first week into early infancy

→ Meningitis particularly important

Meningitis

S. agalactiae is an important cause of:

Neonatal bacterial meningitis

Possible manifestations include:

• Fever or temperature instability

• Poor feeding

• Lethargy

• Irritability

• Apnea

• Seizures

• Bulging fontanelle

Neonatal meningitis may lack the classic findings seen in older children and adults.

Infection During Pregnancy

GBS can cause infections involving the:

Urinary and genital tracts

during pregnancy.

Important manifestations include:

• Asymptomatic bacteriuria

• Cystitis

• Pyelonephritis

• Chorioamnionitis

• Endometritis

GBS Bacteriuria During Pregnancy

Detection of:

GBS in the urine during pregnancy

is clinically important because it suggests substantial maternal colonization and is associated with increased neonatal transmission risk.

Postpartum Endometritis

GBS may contribute to:

Postpartum uterine infection

Clinical manifestations can include:

• Fever

• Lower abdominal or uterine tenderness

• Abnormal postpartum discharge

• Systemic illness

Adult Group B Streptococcal Disease

GBS is not exclusively a neonatal pathogen.

The source emphasizes increasing recognition of infection in:

Men and nonpregnant women

Invasive Disease in Nonpregnant Adults

GBS can cause:

• Bacteremia

• Sepsis

• Skin and soft-tissue infection

• Pneumonia

• Urinary tract infection

• Osteomyelitis

• Septic arthritis

• Endocarditis

Invasive disease is particularly important among:

Older adults and medically vulnerable patients

High-Yield Adult Pattern

Older or medically complex adult

• ●

Bacteremia, cellulitis, UTI, or osteoarticular infection

• ●

Group B Streptococcus

→ S. agalactiae can be a true invasive pathogen

Diagnosis

The primary diagnostic method is:

CULTURE

Appropriate specimens depend on the clinical syndrome and include:

• Blood

• CSF

• Urine

• Genital specimens

• Other normally sterile fluids

Antigen Detection

The source also describes:

Antigen detection techniques

in body fluids, including:

CSF

as potential diagnostic methods.

In contemporary practice, culture and molecular methods are generally more important for establishing invasive infection.

Maternal Screening

An important preventive strategy is:

Screening pregnant patients for GBS colonization late in pregnancy

using appropriate vaginal and rectal specimens.

The purpose is to identify patients who should receive:

Intrapartum antibiotic prophylaxis

to prevent early-onset neonatal disease.

Treatment

The source identifies:

PENICILLIN G

or:

AMPICILLIN

as primary treatment options.

GBS has traditionally remained highly susceptible to:

β-lactam antibiotics

making penicillin the classic drug of choice.

Neonatal Empiric Therapy

When serious neonatal infection is suspected before the organism is known, empiric treatment commonly needs to cover several neonatal pathogens.

A classic empiric combination is:

Ampicillin + an aminoglycoside such as gentamicin

with the final regimen adjusted once culture results identify the pathogen and infection site.

Additional Treatment

The source lists:

Macrolide antibiotics

as additional therapy.

However, macrolide resistance can occur in GBS.

Therefore, macrolides should not automatically be assumed to be active without:

Susceptibility information

when they are being considered for treatment.

Prevention of Neonatal Disease

One of the most important aspects of GBS management is:

INTRAPARTUM ANTIBIOTIC PROPHYLAXIS

Eligible colonized pregnant patients receive antibiotics:

During labor

to reduce neonatal exposure to the organism.

Why Intrapartum Prophylaxis Works

Maternal GBS colonization

↓

Antibiotic administered during labor

↓

Reduced maternal genital bacterial burden

↓

Reduced neonatal exposure

↓

Reduced:

EARLY-ONSET GBS DISEASE

Important Prevention Pearl

Intrapartum prophylaxis is particularly effective against:

Early-onset neonatal GBS disease

It does not provide equivalent prevention of:

Late-onset disease

Streptococcus agalactiae vs. Streptococcus pyogenes

Both are:

β-hemolytic streptococci

but they belong to different Lancefield groups.

S. agalactiae

→ Group B

→ CAMP positive

→ Bacitracin resistant

→ Neonatal sepsis/meningitis

→ Maternal genital colonization

S. pyogenes

→ Group A

→ CAMP negative

→ Classically bacitracin susceptible

→ Pharyngitis, impetigo, cellulitis, scarlet fever, rheumatic fever

High-Yield Comparison

Group A

→ S. pyogenes

Group B

→ S. agalactiae

Streptococcus agalactiae vs. Listeria monocytogenes

Both are important causes of:

Neonatal sepsis and meningitis

However:

S. agalactiae

→ Gram-positive coccus

→ Group B Streptococcus

→ CAMP positive

→ Maternal genital colonization

Listeria monocytogenes

→ Gram-positive bacillus

→ Intracellular organism

→ Tumbling motility

→ Associated with pregnancy, neonates, older adults, and impaired cellular immunity

Prevention

Important preventive measures include:

• Maternal GBS screening

• Appropriate intrapartum antibiotic prophylaxis

• Recognition of GBS bacteriuria during pregnancy

• Recognition of previous neonatal invasive GBS disease

• Prompt evaluation of symptomatic newborns

High-Yield Clinical Pattern

Pregnant patient

• ●

Rectovaginal GBS colonization

↓

Transmission during delivery

↓

Newborn develops sepsis/pneumonia during first days of life

→ Think STREPTOCOCCUS AGALACTIAE

High-Yield Microbiology Pattern

β-hemolytic GPC

• ●

Catalase negative

• ●

CAMP positive

• ●

Group B

• ●

Neonatal sepsis/meningitis

→ S. AGALACTIAE

Exam Essentials

Genus: Streptococcus

Species: S. agalactiae

Lancefield group: B

Common name: Group B Streptococcus (GBS)

Organism: Gram-positive coccus

Arrangement: Chains or pairs

Catalase: Negative

Hemolysis: Usually β-hemolytic

CAMP test: Positive

Hippurate: Positive

Classic bacitracin pattern: Resistant

Distribution: Worldwide

Reservoir: Gastrointestinal and female genital tracts

Early-onset disease: First 0–6 days of life

Major early-onset manifestations: Sepsis and pneumonia, with meningitis possible

Important late-onset manifestation: Meningitis

Maternal disease: UTI/bacteriuria, chorioamnionitis, and endometritis

Adult disease: Increasingly important cause of invasive infection in nonpregnant adults

Diagnosis: Culture

Classic treatment: Penicillin G or ampicillin

Prevention: Maternal screening + intrapartum antibiotic prophylaxis

Memory Aid

GROUP B = BABY

B = Baby

B = Birth transmission

B = Bacteremia

B = Brain infection (meningitis)

And:

CAMP = Group B

CAMP-positive β-hemolytic Streptococcus

→ Think S. agalactiae

Key clinical pearl: Streptococcus agalactiae is Group B Streptococcus, a CAMP-positive, usually β-hemolytic Gram-positive coccus that colonizes the maternal gastrointestinal and genital tracts. Its classic clinical importance is vertical transmission during delivery, producing early-onset neonatal sepsis and pneumonia and potentially meningitis. Maternal screening and appropriate intrapartum antibiotic prophylaxis are central to preventing early-onset neonatal GBS disease, while penicillin or ampicillin remains the classic definitive therapy for susceptible invasive infection.

Infectious Disease and Microbiology – Streptobacillus moniliformis

Overview

Streptobacillus moniliformis is a pleomorphic Gram-negative bacillus and an important cause of rat-bite fever, also called streptobacillosis. Infection usually follows a rat bite or scratch, although exposure to contaminated food or water can produce an outbreak-associated form historically known as Haverhill fever.

The classic illness begins with fever, headache, and malaise, followed by a maculopapular or petechial rash and prominent migratory arthralgia or polyarthritis. Untreated infection can occasionally progress to serious complications such as endocarditis, pericarditis, tenosynovitis, and metastatic abscesses.

Classification

Genus: Streptobacillus

Species: Streptobacillus moniliformis

Organism: Pleomorphic Gram-negative bacillus

Major disease: Rat-bite fever (streptobacillosis)

Food/water-associated syndrome: Haverhill fever

Microbiologic Characteristics

S. moniliformis is a:

• Pleomorphic Gram-negative bacillus

• Fastidious organism

• Nonmotile bacterium

• Rat-associated zoonotic pathogen

• Organism requiring specialized conditions for optimal laboratory recovery

Its cells may form:

Chains and filamentous structures with irregular swellings

The term:

moniliformis

refers to a:

Beaded or necklace-like appearance

High-Yield Microbiology Pattern

Pleomorphic Gram-negative bacillus

• ●

Rat exposure

• ●

Fever

• ●

Rash

• ●

Migratory polyarthralgia/polyarthritis

→ Think Streptobacillus moniliformis

Incubation Period

The usual incubation period is:

3–10 days

although it may occasionally be:

Longer

Symptoms therefore typically develop within approximately a week after rodent exposure.

Epidemiology

S. moniliformis has a:

Worldwide distribution

Human disease remains relatively:

Rare

including in:

• North America

• Europe

However, S. moniliformis is the classic cause of rat-bite fever in:

North America

Rat Reservoir

The major reservoir is:

RATS

The organism can colonize the:

Nasopharyngeal and upper respiratory flora of rodents

without causing obvious disease in the animal.

Transmission

Most patients report:

A RAT BITE

However, transmission can also occur through:

• Rat scratches

• Contact with rodent secretions

• Handling infected rodents

• Exposure to contaminated food or water

Rat-Bite Fever

The major clinical syndrome is:

RAT-BITE FEVER

also known as:

Streptobacillosis

The illness usually begins abruptly after the incubation period.

Clinical Manifestations

The classic initial manifestations include:

• Fever

• Headache

• Malaise

• Chills

• Myalgia

These systemic symptoms are typically followed by:

Rash + arthralgia/polyarthritis

Rash

A characteristic:

Maculopapular rash

may develop after the initial febrile illness.

The eruption may also become:

• Petechial

• Purpuric

• Vesicular in some patients

Lesions frequently involve the:

Extremities

and may involve:

Palms and soles

High-Yield Rash Pattern

Rat exposure

• ●

Fever

• ●

Maculopapular/petechial rash involving extremities

• ●

Arthralgia

→ Think S. moniliformis

Musculoskeletal Disease

One of the most useful clinical clues is:

MIGRATORY POLYARTHRALGIA

or:

POLYARTHRITIS

Patients may develop pain and inflammation involving multiple joints.

Tenosynovitis can also occur.

Classic Clinical Triad

FEVER

• ●

RASH

• ●

MIGRATORY POLYARTHRALGIA/POLYARTHRITIS

after:

RAT EXPOSURE

→ STREPTOBACILLUS MONILIFORMIS

Bite Wound

An important point is that the original rat-bite wound may:

Heal before systemic symptoms develop

Therefore, absence of an actively inflamed bite site does not exclude:

Streptobacillary rat-bite fever

Haverhill Fever

S. moniliformis can also produce:

HAVERHILL FEVER

This syndrome results from ingestion of:

Food or water contaminated with rat-associated organisms

rather than direct inoculation through a bite.

Haverhill Fever Pattern

Contaminated food or water

↓

S. moniliformis

↓

Fever

• ●

Rash

• ●

Arthralgia/arthritis

This can result in:

Outbreaks involving multiple people

rather than isolated cases following individual rat bites.

Rat-Bite Fever vs. Haverhill Fever

Rat-Bite Fever

Transmission: Rat bite/scratch or direct rodent exposure

Organism: S. moniliformis

Features: Fever, rash, arthralgia/polyarthritis

Haverhill Fever

Transmission: Ingestion of contaminated food or water

Organism: S. moniliformis

Features: Similar systemic illness, often with prominent pharyngitis and vomiting

Complications

Untreated streptobacillosis may occasionally result in serious invasive complications.

The source identifies:

• Endocarditis

• Pericarditis

• Tenosynovitis

• Abscesses in multiple organs

Endocarditis

One of the most serious complications is:

INFECTIVE ENDOCARDITIS

Persistent fever or bacteremia, cardiac findings, or embolic manifestations should raise concern for:

Endocardial infection

Pericarditis

Cardiac involvement may also include:

PERICARDITIS

although this is considerably less common than uncomplicated febrile disease.

Tenosynovitis

Inflammation of tendon sheaths can produce:

TENOSYNOVITIS

This fits with the strong musculoskeletal involvement characteristic of:

Streptobacillary rat-bite fever

Metastatic Abscesses

Untreated infection may disseminate hematogenously and produce:

Abscesses in internal organs

The source specifically notes possible involvement of the:

Brain

Therefore, neurologic manifestations in severe untreated disease should raise concern for:

CNS complications

Diagnosis

The source recommends:

CULTURE IN SPECIFIC MEDIA

S. moniliformis is:

Fastidious

and can be difficult to recover using routine laboratory techniques.

Laboratory Communication

When rat-bite fever is suspected, the:

Microbiology laboratory should be informed

because specialized culture conditions and specimen handling may be required.

This is particularly important because routine laboratory procedures may fail to recover the organism.

Culture

Potential specimens include:

• Blood

• Synovial fluid

• Other normally sterile specimens

Culture may require:

Specialized enriched media

because of the organism’s fastidious growth requirements.

Important Culture Pearl

Certain routine blood-culture media historically contained:

Sodium polyanethol sulfonate (SPS)

which can inhibit growth of:

S. moniliformis

This helps explain why routine blood cultures may occasionally be negative despite compatible disease.

Molecular Diagnosis

When available, molecular methods such as:

PCR

may assist with diagnosis, particularly when conventional culture is unsuccessful.

Treatment

The classic treatment is:

PENICILLIN

S. moniliformis is traditionally highly susceptible to penicillin, making β-lactam therapy a cornerstone of treatment.

Additional Treatment

The source lists:

• Doxycycline

• Azithromycin

as additional therapeutic options.

Treatment selection should account for:

Disease severity + allergy history + infection site + complications

Complicated Disease

More prolonged and intensive antimicrobial therapy may be necessary when infection is complicated by:

• Endocarditis

• CNS infection

• Deep abscess

• Septic arthritis

• Other metastatic infection

Drainable abscesses may additionally require:

Source control

Streptobacillus moniliformis vs. Spirillum minus

This is the most important examination comparison.

Both cause:

RAT-BITE FEVER

but their epidemiology and clinical patterns differ.

Streptobacillus moniliformis

→ Pleomorphic Gram-negative bacillus

→ More classically associated with North America

→ Incubation usually 3–10 days

→ Fever + rash + migratory polyarthralgia/polyarthritis

→ Bite wound often heals

→ Can cause Haverhill fever through contaminated food/water

Spirillum minus

→ Spiral Gram-negative organism

→ Classically associated with Asia, especially Japan

→ Causes sodoku

→ Incubation may extend to several weeks

→ Relapsing fever prominent

→ Bite site may become inflamed again

→ Regional lymphadenopathy is characteristic

High-Yield Comparison

Rat bite + fever + rash + migratory polyarthritis + North America

→ Streptobacillus moniliformis

Rat bite + relapsing fever + recurrent bite-site inflammation + lymphadenopathy + Asia/Japan

→ Spirillum minus

Prevention

Prevention focuses on minimizing exposure to:

Rodents and rodent secretions

Important measures include:

• Rodent control

• Protective handling of laboratory or pet rodents

• Avoiding contact with wild rats

• Prompt cleansing of rat bites and scratches

• Protecting food and drinking water from rodent contamination

• Seeking medical evaluation if fever develops after a rodent bite

High-Yield Clinical Pattern

Rat bite

• ●

3–10 day incubation

• ●

Fever and headache

• ●

Maculopapular/petechial rash

• ●

Migratory polyarthralgia or polyarthritis

→ Think STREPTOBACILLUS MONILIFORMIS

High-Yield Haverhill Pattern

No rat bite required

• ●

Rodent-contaminated food or water

• ●

Outbreak of fever + rash + arthralgia

→ Think HAVERHILL FEVER due to S. moniliformis

Exam Essentials

Genus: Streptobacillus

Species: S. moniliformis

Organism: Pleomorphic Gram-negative bacillus

Major reservoir: Rats

Distribution: Worldwide

Incubation: 3–10 days, sometimes longer

Major transmission: Rat bite or scratch

Major disease: Rat-bite fever / streptobacillosis

Food/water-associated form: Haverhill fever

Classic manifestations: Fever + rash + migratory polyarthralgia/polyarthritis

Rash: Maculopapular/petechial, often involving extremities and potentially palms/soles

Important complications: Endocarditis, pericarditis, tenosynovitis, and metastatic abscesses

Diagnosis: Specialized culture; molecular testing may assist

Culture pearl: Some routine blood-culture conditions may inhibit growth

Classic treatment: Penicillin

Additional source treatments: Doxycycline and azithromycin

Major differential: Spirillum minus

Prevention: Rodent control, wound care, and protection of food/water from rodent contamination

Memory Aid

STREPTOBACILLUS = STRAIGHT TO THE JOINTS

Rat exposure

→ S. moniliformis

→ Fever

→ Rash

→ Migratory joint pain/polyarthritis

And remember:

HAVERHILL = HAVE A DRINK

Contaminated food or water can transmit S. moniliformis without a rat bite.

Key clinical pearl: Streptobacillus moniliformis is the classic North American cause of rat-bite fever. Think of it when a patient develops fever, a maculopapular or petechial rash, and migratory polyarthralgia or polyarthritis several days after rat exposure. Unlike Spirillum minus sodoku, the bite wound may already have healed, and ingestion of rodent-contaminated food or water can produce Haverhill fever. Because the organism is fastidious, the microbiology laboratory should be alerted when infection is suspected; penicillin is the classic treatment.

Infectious Disease and Microbiology – Stomatococcus mucilaginosus

Overview

Stomatococcus mucilaginosus is a Gram-positive coccus that is part of the normal flora of the human oral cavity and upper respiratory tract. Although usually a low-virulence commensal, it can become an opportunistic pathogen, particularly in patients with neutropenia, oral mucosal damage, malignancy, or central venous catheters.

An important modern taxonomy point is that Stomatococcus mucilaginosus has been reclassified as:

Rothia mucilaginosa

Thus, Stomatococcus mucilaginosus is the historical name, while Rothia mucilaginosa is the currently accepted name.

Classification

Historical genus: Stomatococcus

Historical species: Stomatococcus mucilaginosus

Current name: Rothia mucilaginosa

Organism: Gram-positive coccus

Clinical behavior: Opportunistic pathogen

Major reservoir: Human oral cavity

Microbiologic Characteristics

The source describes S. mucilaginosus as an:

Aerobic Gram-positive coccus

It is generally:

• Gram positive

• Catalase positive

• Nonmotile

• Non-spore-forming

• Part of normal oral flora

• Capable of producing characteristically mucoid or sticky colonies

The term:

mucilaginosa

reflects this characteristic:

Mucilaginous/sticky colony appearance

High-Yield Microbiology Pattern

Gram-positive coccus

• ●

Normal oral flora

• ●

Mucoid/sticky colonies

• ●

Neutropenic patient with mucositis and bacteremia

→ Think Rothia mucilaginosa

(formerly Stomatococcus mucilaginosus)

Epidemiology

The organism has a:

Worldwide distribution

Clinically significant infection is:

Rare

Because it normally colonizes the mouth and upper respiratory tract, many infections are thought to originate from:

Endogenous oral flora

Major Risk Factors

Invasive infection occurs predominantly in susceptible patients.

Important risk factors include:

• Neutropenia

• Hematologic malignancy

• Chemotherapy

• Oral mucositis

• Central venous catheters

• Immunosuppression

• Broad-spectrum antibiotic exposure

High-Yield Host Pattern

Neutropenia

• ●

Chemotherapy-associated oral mucositis

• ●

Central venous catheter

• ●

Gram-positive bacteremia

→ Consider Rothia mucilaginosa

Oral Mucositis

The source emphasizes the association between S. mucilaginosus and:

Oral mucositis in neutropenic patients

Mucosal injury can disrupt the normal oral barrier.

This creates the sequence:

Chemotherapy/neutropenia

↓

Oral mucosal damage

↓

Normal oral flora crosses damaged mucosa

↓

Bloodstream invasion

↓

Bacteremia

Antibiotic Exposure

The source particularly notes infection in neutropenic patients receiving antibiotics for:

Intestinal decontamination

Broad antimicrobial exposure can alter normal microbial flora and provide selective pressure favoring opportunistic organisms.

Bacteremia

One of the most important clinical manifestations is:

BACTEREMIA

The source particularly associates bloodstream infection with:

Central venous catheters

Patients with neutropenia and mucositis may simultaneously have:

Mucosal barrier disruption + central venous access

which substantially increases the importance of a positive blood culture.

High-Yield Bacteremia Pattern

Patient with hematologic malignancy

• ●

Neutropenia

• ●

Severe oral mucositis

• ●

Central venous catheter

• ●

Rothia mucilaginosa in blood cultures

→ Consider true opportunistic bacteremia

Central Venous Catheter Infection

Central venous catheters can provide a surface for:

Microbial adherence and persistent bloodstream infection

Therefore, when bacteremia occurs, clinicians should evaluate whether the catheter represents:

The source or a persistent focus of infection

Endocarditis

The organism can occasionally cause:

INFECTIVE ENDOCARDITIS

Endocardial infection is uncommon but potentially serious.

Persistent bacteremia, a new murmur, embolic manifestations, or other compatible findings should prompt evaluation for:

Endocarditis

Meningitis

The source also identifies:

MENINGITIS

as a potential invasive manifestation.

Although rare, CNS infection demonstrates that R. mucilaginosa can behave as a significant invasive pathogen in susceptible patients.

Other Invasive Disease

In severely immunocompromised hosts, bloodstream dissemination may potentially produce infection at additional sites.

The most important principle is that isolation from a normally sterile site in a compatible high-risk patient should not automatically be dismissed as:

Contamination

Diagnosis

The primary diagnostic method is:

CULTURE

Appropriate specimens include:

• Blood

• CSF

• Catheter-associated specimens

• Other normally sterile fluids or tissues

Blood Cultures

Multiple positive blood cultures increase the likelihood of:

True bacteremia

particularly when accompanied by:

• Fever

• Neutropenia

• Oral mucositis

• Central venous catheter

• Clinical evidence of systemic infection

Identification Challenges

Because the organism is an unusual Gram-positive member of oral flora, laboratory identification can sometimes be confused with other organisms such as:

• Coagulase-negative Staphylococcus

• Micrococcus

• Other Rothia species

Accurate species identification is therefore useful in a compatible clinical setting.

Contaminant vs. True Pathogen

A major clinical question is whether recovery represents:

Contamination

or

True infection

Evidence favoring true infection includes:

Repeated positive cultures

• ●

Neutropenia

• ●

Oral mucositis

• ●

Central venous catheter

• ●

Compatible fever or sepsis

Treatment

The source lists:

VANCOMYCIN

and

CARBAPENEMS

as important treatments.

Because invasive infections are uncommon and antimicrobial susceptibility may vary, treatment should ultimately be guided by:

Culture and susceptibility results

Vancomycin

Vancomycin is an important option for serious invasive infection, particularly when susceptibility information is not yet available.

This can be relevant in:

• Bacteremia

• Central-line infection

• Endocarditis

• Meningitis

Additional Treatment

The source lists:

• Penicillin G

• Macrolides

as additional potential treatments.

Definitive selection should depend on:

Susceptibility + infection site + severity + patient factors

Source Control

For central venous catheter-associated infection, management should include assessment of the:

Catheter

Persistent or complicated infection may require:

Catheter removal or replacement

in addition to appropriate antimicrobial therapy.

Stomatococcus mucilaginosus vs. Rothia dentocariosa

Both are now classified within the genus:

Rothia

and both are associated with the:

Oral cavity

However, their classic clinical associations differ.

Rothia mucilaginosa

Formerly Stomatococcus mucilaginosus

→ Oral flora

→ Neutropenia

→ Oral mucositis

→ Central venous catheter-associated bacteremia

→ Opportunistic invasive disease

Rothia dentocariosa

→ Oral/dental flora

→ Dental caries and periodontal disease

→ Particularly associated with endocarditis

High-Yield Distinction

Neutropenia + mucositis + bacteremia

→ Rothia mucilaginosa

Dental disease + subacute endocarditis

→ Rothia dentocariosa

Stomatococcus vs. Staphylococcus

Both may appear as:

Gram-positive cocci

but their clinical patterns differ.

Staphylococcus aureus

→ Major virulent pathogen

→ Abscesses and purulent infections

→ Coagulase positive

Staphylococcus epidermidis

→ Skin flora

→ Prosthetic/device-associated infection

Rothia mucilaginosa

→ Oral flora

→ Particularly associated with neutropenia and mucositis

→ Rare opportunistic bloodstream infection

Prevention

There is no specific vaccine.

Prevention in high-risk patients focuses on:

• Appropriate oral hygiene

• Management of chemotherapy-associated mucositis

• Proper central venous catheter care

• Hand hygiene

• Appropriate infection-control practices

• Removal of unnecessary invasive devices

High-Yield Clinical Pattern

Neutropenic patient

• ●

Oral mucositis

• ●

Central venous catheter

• ●

Gram-positive coccus in blood cultures

• ●

Mucoid/sticky colonies

→ Think ROTHIA MUCILAGINOSA

(formerly STOMATOCOCCUS MUCILAGINOSUS)

Exam Essentials

Historical name: Stomatococcus mucilaginosus

Current name: Rothia mucilaginosa

Organism: Gram-positive coccus

Distribution: Worldwide

Frequency: Rare infection

Normal habitat: Oral cavity/upper respiratory tract

Major risk factor: Neutropenia

Classic clinical association: Chemotherapy-associated oral mucositis

Important device association: Central venous catheter

Major infection: Bacteremia

Other serious infections: Endocarditis and meningitis

Diagnosis: Culture

Source-listed treatments: Vancomycin and carbapenems

Additional source-listed agents: Penicillin G and macrolides

Treatment principle: Use susceptibility-guided therapy for significant invasive infection

Management principle: Evaluate for catheter source and need for source control

Memory Aid

MUCILAGINOSA = MUCOSITIS

Rothia mucilaginosa

→ Mucosal/oral flora

→ Mucositis

→ Malignancy/neutropenia

→ Medical catheter

→ Microbial bloodstream invasion

Key clinical pearl: The organism historically called Stomatococcus mucilaginosus is now classified as Rothia mucilaginosa. It is an oral commensal that becomes an important opportunistic pathogen in neutropenic patients, especially those with chemotherapy-associated oral mucositis and central venous catheters. In that setting, recovery from blood cultures should not automatically be dismissed as contamination because true bacteremia, endocarditis, and occasionally meningitis can occur.

Infectious Disease and Microbiology – Stenotrophomonas Species

Overview

Stenotrophomonas species are aerobic Gram-negative bacilli found widely in water and moist environmental settings. The most clinically important species is Stenotrophomonas maltophilia, an opportunistic pathogen particularly associated with healthcare-associated infections.

S. maltophilia is especially important in patients with prolonged hospitalization, ICU stays, mechanical ventilation, invasive devices, immunocompromise, or extensive prior exposure to broad-spectrum antibiotics. A defining clinical feature is its intrinsic resistance to many antimicrobial agents, especially carbapenems.

Classification

Genus: Stenotrophomonas

Species described in the source include:

• Stenotrophomonas africana

• Stenotrophomonas maltophilia

The major human pathogen is:

Stenotrophomonas maltophilia

Microbiologic Characteristics

Stenotrophomonas species are:

• Aerobic Gram-negative bacilli

• Nonfermenting organisms

• Generally motile

• Environmental organisms

• Particularly adapted to moist environments

• Opportunistic human pathogens

S. maltophilia was historically classified under other genera, including:

Pseudomonas maltophilia

and later:

Xanthomonas maltophilia

before being placed in the genus Stenotrophomonas.

High-Yield Microbiology Pattern

Aerobic Gram-negative bacillus

• ●

Nonfermenter

• ●

Moist environmental reservoir

• ●

Nosocomial infection

• ●

Carbapenem resistance

→ Think STENOTROPHOMONAS MALTOPHILIA

Incubation Period

The incubation period is:

Unclear

Because infections are usually opportunistic and healthcare-associated, there is no characteristic incubation interval.

Epidemiology

Stenotrophomonas has a:

Worldwide distribution

The organism is particularly associated with:

Water and moist environments

and may be encountered in hospital environments and patient secretions.

Hydrophilic Nature

The source describes these organisms as:

Hydrophilic bacteria

This environmental preference helps explain their association with:

• Respiratory secretions

• Hospital water sources

• Moist medical equipment

• Respiratory devices

• Indwelling medical devices

Nosocomial Infection

S. maltophilia is an important cause of:

HEALTHCARE-ASSOCIATED INFECTION

Risk is particularly increased in patients with:

• Prolonged hospitalization

• Long ICU stays

• Mechanical ventilation

• Endotracheal intubation

• Central venous catheters

• Immunosuppression

• Severe underlying illness

• Previous broad-spectrum antibiotic exposure

Prior Antibiotic Exposure

One of the most important epidemiologic clues is:

PROLONGED BROAD-SPECTRUM ANTIBIOTIC THERAPY

Broad-spectrum antibiotics can suppress competing bacterial flora while selecting for intrinsically resistant organisms such as:

S. maltophilia

This is particularly important after exposure to agents that have little activity against the organism.

High-Yield Risk Pattern

ICU patient

• ●

Prolonged broad-spectrum antibiotics

• ●

Mechanical ventilation

• ●

Nonfermenting Gram-negative bacillus

→ Think S. maltophilia

Major Infections

The source identifies:

• Bacteremia

• Pneumonia

• Ventilator-associated pneumonia

• Skin and soft-tissue infection

• Urinary tract infection

as important clinical manifestations.

Pneumonia

Respiratory infection is one of the most important manifestations of S. maltophilia disease.

It is particularly associated with:

Hospitalized and mechanically ventilated patients

and can cause:

Ventilator-associated pneumonia

High-Yield Pneumonia Pattern

ICU

• ●

Intubation

• ●

Prolonged antibiotic exposure

• ●

Hospital-acquired pneumonia

• ●

S. maltophilia isolated from respiratory culture

→ Consider Stenotrophomonas pneumonia

Respiratory Colonization vs. Infection

A major clinical challenge is distinguishing:

Colonization

from:

True respiratory infection

because S. maltophilia can colonize respiratory secretions, particularly in patients with chronic respiratory disease or prolonged hospitalization.

Isolation from sputum alone does not necessarily establish pneumonia.

Evidence supporting true infection includes:

New or progressive pulmonary infiltrates

• ●

Fever or systemic inflammatory findings

• ●

Purulent respiratory secretions

• ●

Clinical deterioration

• ●

Compatible microbiologic findings

Bacteremia

S. maltophilia can cause:

Bloodstream infection

especially in patients with:

• Central venous catheters

• Malignancy

• Neutropenia

• Prolonged hospitalization

• Broad-spectrum antibiotic exposure

Central venous catheters may provide an important portal of infection.

High-Yield Bacteremia Pattern

Immunocompromised hospitalized patient

• ●

Central venous catheter

• ●

Broad-spectrum antibiotics

• ●

Nonfermenting GNB bacteremia

→ Consider S. maltophilia

Skin and Soft-Tissue Infection

S. maltophilia may cause:

Skin and soft-tissue infections

particularly in patients with disrupted skin barriers.

Risk factors include:

• Surgery

• Trauma

• Chronic wounds

• Invasive procedures

• Immunocompromise

Urinary Tract Infection

Urinary tract infection can occur, especially in patients with:

• Urinary catheters

• Structural urinary abnormalities

• Repeated urinary instrumentation

• Prolonged hospitalization

As with respiratory specimens, urinary isolation should be interpreted in the context of:

Symptoms + urinalysis + quantitative culture + patient risk factors

to distinguish infection from colonization.

Other Opportunistic Infections

Although not emphasized in the source, invasive S. maltophilia infection can occasionally involve other sites, particularly in severely immunocompromised patients.

The overall clinical pattern remains that of an:

Opportunistic, healthcare-associated Gram-negative pathogen

Diagnosis

The primary diagnostic method is:

CULTURE

Depending on the clinical syndrome, specimens may include:

• Blood

• Respiratory secretions

• Urine

• Wound specimens

• Tissue

• Other normally sterile fluids

Antimicrobial Susceptibility Testing

Because S. maltophilia has substantial intrinsic and acquired antimicrobial resistance, clinically significant isolates should undergo:

Antimicrobial susceptibility testing

Treatment should then be guided by:

Site of infection + severity + susceptibility profile + patient factors

Antimicrobial Resistance

One of the most important features of S. maltophilia is:

MULTIDRUG RESISTANCE

The organism possesses several resistance mechanisms, including:

• β-lactamases

• Efflux pumps

• Reduced antimicrobial permeability

• Other intrinsic resistance determinants

Carbapenem Resistance

A classic examination point is that:

S. maltophilia is intrinsically resistant to carbapenems

This is highly clinically relevant because carbapenems are commonly used to treat severe infections caused by other resistant Gram-negative bacilli.

Thus:

Gram-negative infection persists despite carbapenem therapy

• ●

S. maltophilia isolated

→ Carbapenem resistance is expected rather than surprising.

High-Yield Resistance Pattern

Nosocomial GNB

• ●

Carbapenem resistant

• ●

TMP-SMX susceptible

→ Think STENOTROPHOMONAS MALTOPHILIA

Aztreonam Resistance

The source also notes resistance to:

Aztreonam

in many S. maltophilia isolates.

Therefore, neither carbapenems nor aztreonam alone should be assumed to provide reliable treatment.

Treatment

The classic treatment listed in the source is:

TRIMETHOPRIM–SULFAMETHOXAZOLE

TMP-SMX has traditionally been considered a major therapeutic agent for susceptible S. maltophilia infections.

Additional Treatment Options

The source lists:

• Ceftazidime

• Ciprofloxacin

• Minocycline

• Piperacillin–tazobactam

• Ticarcillin-based therapy

• Aztreonam–clavulanate combinations

However, S. maltophilia susceptibility is variable, and some historically used β-lactams may not provide reliable contemporary activity.

For serious infection, treatment should therefore be:

Susceptibility guided

rather than selected solely from a historical drug list.

Minocycline

Minocycline is an important potential option against susceptible S. maltophilia isolates.

It may be particularly relevant when:

TMP-SMX cannot be used

or when susceptibility results favor minocycline.

Fluoroquinolones

Fluoroquinolones such as:

Levofloxacin or ciprofloxacin

may have activity against selected isolates.

However, resistance can emerge, so susceptibility results and clinical context are important.

Source Control

Management of invasive S. maltophilia infection should include evaluation for:

Infected medical devices

particularly:

Central venous catheters

Source control may involve:

• Removal or replacement of an infected catheter

• Drainage of infected collections

• Wound debridement when necessary

• Removal of unnecessary invasive devices

Stenotrophomonas vs. Pseudomonas aeruginosa

Both are:

Nonfermenting Gram-negative bacilli

and both can cause healthcare-associated pneumonia and bacteremia.

Pseudomonas aeruginosa

→ Major nosocomial pathogen

→ Frequently causes ventilator pneumonia

→ Carbapenems may have activity against susceptible isolates

Stenotrophomonas maltophilia

→ Opportunistic nosocomial pathogen

→ Strong association with previous broad-spectrum antibiotics

→ Frequently colonizes respiratory secretions

→ Intrinsically resistant to carbapenems

→ TMP-SMX historically a classic treatment

Stenotrophomonas vs. Acinetobacter

Both can infect:

Critically ill ICU patients

and both may be multidrug resistant.

Acinetobacter

→ Gram-negative coccobacillus

→ Nonmotile

→ Important ventilator and outbreak-associated pathogen

→ Carbapenem resistance can be acquired and clinically important

Stenotrophomonas

→ Gram-negative bacillus

→ Usually motile

→ Moist environmental organism

→ Intrinsic carbapenem resistance

Prevention

Prevention primarily depends on healthcare infection-control practices:

• Strict hand hygiene

• Appropriate ventilator and respiratory equipment care

• Proper central-line care

• Removal of unnecessary invasive devices

• Environmental infection control

• Avoidance of unnecessary prolonged broad-spectrum antibiotic therapy

• Antimicrobial stewardship

High-Yield Clinical Pattern

Prolonged ICU stay

• ●

Mechanical ventilation

• ●

Previous broad-spectrum antibiotics

• ●

Pneumonia or bacteremia

• ●

Nonfermenting Gram-negative bacillus

• ●

Carbapenem resistance

→ Think STENOTROPHOMONAS MALTOPHILIA

Exam Essentials

Genus: Stenotrophomonas

Important species: S. maltophilia

Other source-listed species: S. africana

Organism: Aerobic Gram-negative bacillus

Metabolism: Nonfermenting

Distribution: Worldwide

Incubation: Unclear

Environmental preference: Water and moist environments

Major setting: Healthcare-associated infection

Major risk factors: Prolonged antibiotics, ICU stay, mechanical ventilation, invasive devices, and immunocompromise

Major infections: Pneumonia/VAP, bacteremia, UTI, and skin/soft-tissue infection

Important diagnostic issue: Respiratory isolation may represent colonization rather than infection

Diagnosis: Culture

Classic treatment: TMP-SMX

Other potential active agents: Minocycline and selected fluoroquinolones, depending on susceptibility

Classic resistance: Carbapenems

Important management principle: Susceptibility-guided therapy + source control

Memory Aid

STENOTROPHOMONAS = SELECTED BY STRONG ANTIBIOTICS

Broad-spectrum antibiotics suppress susceptible flora and create selective pressure favoring this resistant opportunist.

And remember:

MALTOPHILIA → MEROPENEM WON’T FIX IT

because S. maltophilia is intrinsically resistant to carbapenems.

Key clinical pearl: Stenotrophomonas maltophilia is a multidrug-resistant, nonfermenting Gram-negative bacillus that classically emerges in patients with prolonged ICU stays, mechanical ventilation, invasive devices, and extensive prior broad-spectrum antibiotic exposure. It is an important cause of ventilator-associated pneumonia and bacteremia, although respiratory isolation may represent colonization. Its intrinsic carbapenem resistance is a major diagnostic clue, and TMP-SMX is the classic treatment, with definitive therapy guided by susceptibility and infection severity.